p21ras	B-protein
and	O
calcineurin	O
synergize	O
to	O
regulate	O
the	O
nuclear	B-protein
factor	I-protein
of	O
activated	O
T	B-cell_type
cells	I-cell_type
.	O

In	O
T	B-cell_type
lymphocytes	I-cell_type
,	O
triggering	O
of	O
the	O
T	B-protein
cell	I-protein
receptor	I-protein
(	O
TCR	B-protein
)	O
induces	O
several	O
signaling	O
cascades	O
which	O
ultimately	O
synergize	O
to	O
induce	O
the	O
activity	O
of	O
the	O
nuclear	B-protein
factor	I-protein
of	O
activated	O
T	B-cell_type
cells	I-cell_type
(	O
NFAT	B-cell_line
)	O
,	O
a	O
DNA	B-protein
binding	I-protein
complex	I-protein
critical	O
to	O
the	O
inducibility	O
and	O
T	O
cell	O
specificity	O
of	O
the	O
T	B-protein
cell	I-protein
growth	I-protein
factor	I-protein
interleukin	B-protein
2	I-protein
.	O

One	O
immediate	O
consequence	O
of	O
T	O
cell	O
activation	O
via	O
the	O
TCR	B-protein
is	O
an	O
increase	O
in	O
cytosolic	O
calcium	O
.	O

Calcium	O
signals	O
are	O
important	O
for	O
NFAT	B-cell_line
induction	O
,	O
and	O
recent	O
studies	O
have	O
identified	O
calcineurin	B-protein
,	O
a	O
calcium-calmodulin	B-protein
dependent	I-protein
serine-threonine	I-protein
phosphatase	I-protein
,	O
as	O
a	O
prominent	O
component	O
of	O
the	O
calcium	O
signaling	O
pathway	O
in	O
T	B-cell_type
cells	I-cell_type
.	O

A	O
second	O
important	O
molecule	O
in	O
TCR	O
signal	O
transduction	O
is	O
the	O
guanine	B-protein
nucleotide	I-protein
binding	I-protein
protein	I-protein
,	O
p21ras	B-protein
,	O
which	O
is	O
coupled	O
to	O
the	O
TCR	B-protein
by	O
a	O
protein	B-protein
tyrosine	I-protein
kinase	I-protein
dependent	O
mechanism	O
.	O

The	O
experiments	O
presented	O
here	O
show	O
that	O
expression	O
by	O
transfection	O
of	O
mutationally	O
activated	O
calcineurin	B-protein
or	O
activated	O
p21ras	B-protein
alone	O
is	O
insufficient	O
for	O
NFAT	B-cell_type
transactivation	O
.	O

However	O
,	O
coexpression	O
of	O
the	O
activated	O
calcineurin	O
with	O
activated	O
p21ras	O
could	O
mimic	O
TCR	O
signals	O
in	O
NFAT	B-cell_type
induction	O
.	O

These	O
data	O
identify	O
calcineurin	B-protein
and	O
p21ras	B-protein
as	O
cooperative	O
partners	O
in	O
T	B-cell_type
cell	I-cell_type
activation	O
.	O

p21	NULL
``	NULL
and	NULL
Calcineurin	NULL
Synergize	NULL
to	NULL
Regulate	NULL
the	NULL
Nuclear	NULL
Factor	NULL
of	NULL
Activated	NULL
T	NULL
Cells	NULL
By	NULL
M.	NULL
Woodrow	NULL
,	NULL
Neil	NULL
A.	NULL
Clipstone	NULL
,	NULL
*	NULL
and	NULL
D.	NULL
Cantrell	NULL
From	NULL
the	NULL
Lymphocyte	NULL
Activation	NULL
Laboratory	NULL
,	NULL
Imperial	NULL
Cancer	NULL
Research	NULL
Fund	NULL
,	NULL
London	NULL
,	NULL
WC2A	NULL
3PX	NULL
,	NULL
England	NULL
and	NULL
the	NULL
*Beckman	NULL
Center	NULL
for	NULL
Molecular	NULL
and	NULL
Genetic	NULL
Medicine	NULL
,	NULL
Howard	NULL
Hughes	NULL
Medical	NULL
Institute	NULL
,	NULL
Stanford	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Stanford	NULL
,	NULL
California	NULL
94305	NULL
Summary	NULL
In	NULL
T	NULL
lymphocytes	NULL
,	NULL
triggering	NULL
of	NULL
the	NULL
T	NULL
cell	NULL
receptor	NULL
(	NULL
TCR	NULL
)	NULL
induces	NULL
several	NULL
signaling	NULL
cascades	NULL
which	NULL
ultimately	NULL
synergize	NULL
to	NULL
induce	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
NFAT	NULL
)	NULL
,	NULL
a	NULL
DNA	NULL
binding	NULL
complex	NULL
critical	NULL
to	NULL
the	NULL
inducibility	NULL
and	NULL
T	NULL
cell	NULL
specificity	NULL
of	NULL
the	NULL
T	NULL
cell	NULL
growth	NULL
factor	NULL
interleukin	NULL
2	NULL
.	NULL

One	NULL
immediate	NULL
consequence	NULL
of	NULL
T	NULL
cell	NULL
activation	NULL
via	NULL
the	NULL
TCR	NULL
is	NULL
an	NULL
increase	NULL
in	NULL
cytosolic	NULL
calcium	NULL
.	NULL

Calcium	NULL
signals	NULL
are	NULL
important	NULL
for	NULL
NFAT	NULL
induction	NULL
,	NULL
and	NULL
recent	NULL
studies	NULL
have	NULL
identified	NULL
calcineurin	NULL
,	NULL
a	NULL
calcium-calmodulin	NULL
dependent	NULL
serine-threonine	NULL
phosphatase	NULL
,	NULL
as	NULL
a	NULL
prominent	NULL
component	NULL
of	NULL
the	NULL
calcium	NULL
signaling	NULL
pathway	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

A	NULL
second	NULL
important	NULL
molecule	NULL
in	NULL
TCR	NULL
signal	NULL
transduction	NULL
is	NULL
the	NULL
guanine	NULL
nucleotide	NULL
binding	NULL
protein	NULL
,	NULL
p21	NULL
``	NULL
,	NULL
which	NULL
is	NULL
coupled	NULL
to	NULL
the	NULL
TCR	NULL
by	NULL
a	NULL
protein	NULL
tyrosine	NULL
kinase	NULL
dependent	NULL
mechanism	NULL
.	NULL

The	NULL
experiments	NULL
presented	NULL
here	NULL
show	NULL
that	NULL
expression	NULL
by	NULL
transfection	NULL
of	NULL
mutationally	NULL
activated	NULL
calcineurin	NULL
or	NULL
activated	NULL
p21	NULL
``	NULL
alone	NULL
is	NULL
insufficient	NULL
for	NULL
NFAT	NULL
transactivation	NULL
.	NULL

However	NULL
,	NULL
coexpression	NULL
of	NULL
the	NULL
activated	NULL
calcineurin	NULL
with	NULL
activated	NULL
p21	NULL
``	NULL
Â®	NULL
could	NULL
mimic	NULL
TCR	NULL
signals	NULL
in	NULL
NFAT	NULL
induction	NULL
.	NULL

These	NULL
data	NULL
identify	NULL
calcineurin	NULL
and	NULL
p21	NULL
``	NULL
``	NULL
as	NULL
cooperative	NULL
partners	NULL
in	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

lymphocyte	NULL
growth	NULL
is	NULL
controlled	NULL
by	NULL
the	NULL
cytokine	NULL
interleukin	NULL
2	NULL
(	NULL
IL-2	NULL
)	NULL
.	NULL

Quiescent	NULL
T	NULL
cells	NULL
do	NULL
not	NULL
express	NULL
the	NULL
IL-2	NULL
gene	NULL
(	NULL
1	NULL
)	NULL
.	NULL

After	NULL
T	NULL
cell	NULL
activation	NULL
via	NULL
the	NULL
T	NULL
cell	NULL
receptor	NULL
for	NULL
antigen	NULL
(	NULL
TCR	NULL
)	NULL
,	NULL
there	NULL
is	NULL
transcriptional	NULL
induction	NULL
of	NULL
IL-2	NULL
gene	NULL
expression	NULL
(	NULL
2	NULL
)	NULL
.	NULL

The	NULL
target	NULL
for	NULL
TCR-derived	NULL
signals	NULL
in	NULL
the	NULL
IL-2	NULL
gene	NULL
is	NULL
a	NULL
T	NULL
cell-specific	NULL
transcriptional	NULL
enhancer	NULL
located	NULL
in	NULL
a	NULL
region	NULL
275	NULL
bp	NULL
5	NULL
``	NULL
of	NULL
the	NULL
gene	NULL
(	NULL
3	NULL
)	NULL
.	NULL

The	NULL
cooperative	NULL
activity	NULL
of	NULL
at	NULL
least	NULL
eight	NULL
proteins	NULL
that	NULL
interact	NULL
with	NULL
this	NULL
enhancer	NULL
appears	NULL
to	NULL
control	NULL
IL-2	NULL
gene	NULL
transcription	NULL
(	NULL
4	NULL
)	NULL
.	NULL

Several	NULL
of	NULL
these	NULL
proteins	NULL
,	NULL
such	NULL
as	NULL
AP-1	NULL
,	NULL
NFKB	NULL
,	NULL
and	NULL
Oct-1	NULL
are	NULL
ubiquitous	NULL
and	NULL
regulate	NULL
gene	NULL
transcription	NULL
in	NULL
many	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
a	NULL
protein	NULL
complex	NULL
termed	NULL
the	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
NFAT	NULL
)	NULL
'	NULL
has	NULL
been	NULL
identified	NULL
that	NULL
seems	NULL
to	NULL
determine	NULL
both	NULL
the	NULL
T	NULL
cell	NULL
specificity	NULL
and	NULL
inducibility	NULL
of	NULL
IL-2	NULL
gene	NULL
regulation	NULL
(	NULL
5	NULL
)	NULL
.	NULL

In	NULL
particular	NULL
,	NULL
NFAT	NULL
is	NULL
a	NULL
specific	NULL
target	NULL
for	NULL
the	NULL
TCR-derived	NULL
signals	NULL
that	NULL
control	NULL
IL-2	NULL
gene	NULL
expression	NULL
.	NULL

NFAT	NULL
is	NULL
thought	NULL
to	NULL
be	NULL
composed	NULL
of	NULL
two	NULL
proteins	NULL
:	NULL
one	NULL
is	NULL
T	NULL
cell-specific	NULL
,	NULL
cytoplasmic	NULL
,	NULL
and	NULL
translocates	NULL
to	NULL
the	NULL
nucleus	NULL
upon	NULL
T	NULL
cell	NULL
acti-vation	NULL
;	NULL
the	NULL
other	NULL
is	NULL
apparently	NULL
a	NULL
member	NULL
of	NULL
the	NULL
AP1	NULL
family	NULL
of	NULL
transcriptional	NULL
factors	NULL
(	NULL
i.e	NULL
.	NULL

,	NULL
Fos/Jun	NULL
)	NULL
,	NULL
predominantly	NULL
nu-clear	NULL
,	NULL
and	NULL
present	NULL
only	NULL
in	NULL
activated	NULL
cells	NULL
(	NULL
6-10	NULL
)	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
a	NULL
functional	NULL
NFAT	NULL
complex	NULL
in	NULL
T	NULL
cells	NULL
1	NULL
Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
CAT	NULL
,	NULL
chloramphenicol	NULL
acetyl	NULL
transferase	NULL
;	NULL
CNA	NULL
,	NULL
wild	NULL
type	NULL
calcineurin	NULL
A	NULL
subunit	NULL
;	NULL
CNB	NULL
,	NULL
wild	NULL
type	NULL
calcineurin	NULL
B	NULL
subunit	NULL
;	NULL
CNM	NULL
,	NULL
calcineurin	NULL
A	NULL
mutant	NULL
;	NULL
NFAT	NULL
,	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
;	NULL
PKC	NULL
,	NULL
protein	NULL
kinase	NULL
C	NULL
;	NULL
PTK	NULL
,	NULL
protein	NULL
tyrosine	NULL
kinase	NULL
.	NULL

is	NULL
controlled	NULL
by	NULL
synergistic	NULL
signaling	NULL
pathways	NULL
initiated	NULL
by	NULL
the	NULL
TCR	NULL
(	NULL
11	NULL
)	NULL
.	NULL

The	NULL
immediate	NULL
signaling	NULL
consequences	NULL
of	NULL
TCR	NULL
triggering	NULL
include	NULL
activation	NULL
of	NULL
protein	NULL
tyrosines	NULL
kinases	NULL
(	NULL
PTKs	NULL
)	NULL
,	NULL
which	NULL
facilitates	NULL
the	NULL
rapid	NULL
elevation	NULL
of	NULL
intracellular	NULL
calcium	NULL
concentration	NULL
and	NULL
activation	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
(	NULL
PKC	NULL
)	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Calcium	NULL
and	NULL
PKC	NULL
are	NULL
important	NULL
signals	NULL
in	NULL
T	NULL
cell	NULL
activation	NULL
since	NULL
pharmacological	NULL
agents	NULL
such	NULL
as	NULL
calcium	NULL
iono-phores	NULL
and	NULL
phorbol	NULL
esters	NULL
,	NULL
that	NULL
elevate	NULL
intracellular	NULL
calcium	NULL
and	NULL
activate	NULL
PKC	NULL
,	NULL
respectively	NULL
,	NULL
can	NULL
bypass	NULL
the	NULL
requirements	NULL
for	NULL
TCR	NULL
triggering	NULL
and	NULL
synergize	NULL
to	NULL
induce	NULL
a	NULL
functional	NULL
NFAT	NULL
complex	NULL
(	NULL
13	NULL
,	NULL
14	NULL
)	NULL
.	NULL

A	NULL
third	NULL
signaling	NULL
pathway	NULL
that	NULL
involves	NULL
the	NULL
guanine	NULL
nucleotide	NULL
binding	NULL
proteins	NULL
p21	NULL
``	NULL
also	NULL
originates	NULL
from	NULL
the	NULL
TCR	NULL
(	NULL
15-18	NULL
)	NULL
.	NULL

The	NULL
Ras	NULL
proteins	NULL
rapidly	NULL
accumulate	NULL
in	NULL
an	NULL
activated	NULL
GTP-bound	NULL
state	NULL
upon	NULL
TCR	NULL
triggering	NULL
and	NULL
also	NULL
in	NULL
response	NULL
to	NULL
stimulation	NULL
of	NULL
PKC	NULL
.	NULL

However	NULL
,	NULL
although	NULL
the	NULL
TCR	NULL
induces	NULL
PKC	NULL
activation	NULL
,	NULL
PKC	NULL
does	NULL
not	NULL
appear	NULL
to	NULL
mediate	NULL
TCR	NULL
regulation	NULL
of	NULL
p21	NULL
``	NULL
(	NULL
19	NULL
)	NULL
.	NULL

Instead	NULL
,	NULL
the	NULL
TCR	NULL
couples	NULL
to	NULL
p21	NULL
``	NULL
via	NULL
a	NULL
PKC-independent	NULL
mechanism	NULL
requiring	NULL
the	NULL
integrity	NULL
of	NULL
TCR-regulated	NULL
PTKs	NULL
.	NULL

In	NULL
recent	NULL
studies	NULL
,	NULL
it	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
Ras	NULL
function	NULL
is	NULL
essential	NULL
for	NULL
TCR	NULL
signal	NULL
transduction	NULL
as	NULL
judged	NULL
by	NULL
the	NULL
demonstration	NULL
that	NULL
expression	NULL
of	NULL
a	NULL
dominant	NULL
inhibitory	NULL
mutant	NULL
of	NULL
p21	NULL
``	NULL
,	NULL
N17	NULL
ras	NULL
,	NULL
prevents	NULL
TCR	NULL
induction	NULL
of	NULL
NFAT	NULL
and	NULL
the	NULL
IL-2	NULL
gene	NULL
(	NULL
20	NULL
,	NULL
21	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
expression	NULL
of	NULL
a	NULL
constitutively	NULL
activated	NULL
Ras	NULL
protein	NULL
,	NULL
p21	NULL
``	NULL
,	NULL
has	NULL
a	NULL
dominant	NULL
positive	NULL
effect	NULL
on	NULL
NFAT	NULL
induction	NULL
and	NULL
is	NULL
able	NULL
to	NULL
generate	NULL
a	NULL
signal	NULL
1517	NULL
__	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

Â©	NULL
The	NULL
Rockefeller	NULL
University	NULL
Press	NULL
Â«	NULL
0022-1007/93/11/1517/06	NULL
$	NULL
2.00	NULL
Volume	NULL
178	NULL
-	NULL
November	NULL
1993	NULL
1517-1522	NULL
that	NULL
synergizes	NULL
with	NULL
a	NULL
calcium	NULL
signal	NULL
to	NULL
induce	NULL
a	NULL
level	NULL
of	NULL
NFAT	NULL
that	NULL
mimics	NULL
the	NULL
TCR	NULL
response	NULL
.	NULL

The	NULL
calcium-regulated	NULL
signals	NULL
that	NULL
cooperate	NULL
with	NULL
p21	NULL
``	NULL
to	NULL
induce	NULL
NFAT	NULL
have	NULL
not	NULL
yet	NULL
been	NULL
identified	NULL
.	NULL

However	NULL
,	NULL
a	NULL
component	NULL
of	NULL
the	NULL
calcium	NULL
signal	NULL
that	NULL
is	NULL
essential	NULL
for	NULL
TCR	NULL
induction	NULL
of	NULL
NFAT	NULL
has	NULL
recently	NULL
been	NULL
identified	NULL
.	NULL

The	NULL
calcium-calmodulin	NULL
dependent	NULL
phosphatase	NULL
calcineurin	NULL
(	NULL
22-25	NULL
)	NULL
,	NULL
which	NULL
is	NULL
the	NULL
major	NULL
cellular	NULL
target	NULL
for	NULL
the	NULL
immunosuppressive	NULL
drugs	NULL
cyclosporin	NULL
A	NULL
and	NULL
FK506	NULL
in	NULL
vivo	NULL
,	NULL
is	NULL
activated	NULL
in	NULL
response	NULL
to	NULL
TCR	NULL
triggering	NULL
or	NULL
stimulation	NULL
of	NULL
cells	NULL
with	NULL
calcium	NULL
ionophore	NULL
(	NULL
26	NULL
)	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
a	NULL
truncated	NULL
constitutively	NULL
active	NULL
Ca**-independent	NULL
catalytic	NULL
subunit	NULL
of	NULL
calcineurin	NULL
generates	NULL
a	NULL
signal	NULL
that	NULL
can	NULL
substitute	NULL
for	NULL
calcium	NULL
signals	NULL
and	NULL
synergize	NULL
with	NULL
phorbol	NULL
esters	NULL
to	NULL
induce	NULL
the	NULL
IL-2	NULL
gene	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Overexpression	NULL
of	NULL
wild	NULL
type	NULL
calcineurin	NULL
can	NULL
also	NULL
augment	NULL
TCR-induced	NULL
NFAT	NULL
-dependent	NULL
transcription	NULL
(	NULL
23	NULL
)	NULL
.	NULL

The	NULL
potential	NULL
for	NULL
p21	NULL
``	NULL
*	NULL
``	NULL
to	NULL
cooperate	NULL
with	NULL
calcineurin	NULL
has	NULL
not	NULL
yet	NULL
been	NULL
explored	NULL
,	NULL
but	NULL
activation	NULL
of	NULL
ras	NULL
is	NULL
a	NULL
good	NULL
candidate	NULL
for	NULL
the	NULL
physiological	NULL
partner	NULL
for	NULL
calcineurin	NULL
in	NULL
NFAT	NULL
induction	NULL
for	NULL
at	NULL
least	NULL
two	NULL
reasons	NULL
.	NULL

First	NULL
,	NULL
p21	NULL
``	NULL
,	NULL
like	NULL
calcineurin	NULL
,	NULL
has	NULL
an	NULL
essential	NULL
function	NULL
in	NULL
TCR	NULL
regulation	NULL
of	NULL
NFAT	NULL
(	NULL
21	NULL
)	NULL
.	NULL

Second	NULL
,	NULL
p21	NULL
``	NULL
can	NULL
replace	NULL
some	NULL
requirements	NULL
for	NULL
phorbol	NULL
ester	NULL
activation	NULL
of	NULL
PKC	NULL
in	NULL
NFAT	NULL
induction	NULL
.	NULL

Accord-ingly	NULL
,	NULL
the	NULL
object	NULL
of	NULL
the	NULL
present	NULL
study	NULL
was	NULL
to	NULL
examine	NULL
the	NULL
potential	NULL
for	NULL
p21	NULL
``	NULL
and	NULL
calcineurin	NULL
to	NULL
synergize	NULL
during	NULL
T	NULL
cell	NULL
activation	NULL
and	NULL
substitute	NULL
for	NULL
the	NULL
TCR	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
NFAT	NULL
.	NULL

The	NULL
present	NULL
data	NULL
show	NULL
that	NULL
in	NULL
two	NULL
T	NULL
cell	NULL
lines	NULL
,	NULL
the	NULL
human	NULL
leukemia	NULL
Jurkat	NULL
and	NULL
the	NULL
murine	NULL
thymoma	NULL
EL4	NULL
,	NULL
expression	NULL
of	NULL
either	NULL
constitutively	NULL
active	NULL
p21	NULL
``	NULL
or	NULL
a	NULL
constitutively	NULL
active	NULL
calcineurin	NULL
is	NULL
not	NULL
alone	NULL
sufficient	NULL
for	NULL
NFAT	NULL
transcription	NULL
.	NULL

However	NULL
,	NULL
in	NULL
combination	NULL
,	NULL
activated	NULL
p21	NULL
'	NULL
``	NULL
and	NULL
calcineurin	NULL
can	NULL
synergize	NULL
to	NULL
give	NULL
induction	NULL
of	NULL
NFAT	NULL
that	NULL
mimics	NULL
the	NULL
response	NULL
induced	NULL
by	NULL
TCR	NULL
.	NULL

These	NULL
data	NULL
further	NULL
define	NULL
TCR	NULL
signal	NULL
transduction	NULL
as	NULL
involving	NULL
cooperative	NULL
interactions	NULL
between	NULL
signals	NULL
by	NULL
calcineurin	NULL
and	NULL
p21	NULL
``	NULL
``	NULL
controlled	NULL
signaling	NULL
pathways	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Reagents	NULL
Tonomycin	NULL
(	NULL
calcium	NULL
salt	NULL
)	NULL
and	NULL
phorbol-12	NULL
,	NULL
13-di-butyrate	NULL
were	NULL
from	NULL
Calbiochem	NULL
Corp.	NULL
(	NULL
UK	NULL
)	NULL
.	NULL

UCHT1	NULL
(	NULL
reactive	NULL
for	NULL
human	NULL
CD3	NULL
)	NULL
was	NULL
used	NULL
at	NULL
10	NULL
pg/ml	NULL
in	NULL
culture	NULL
(	NULL
27	NULL
)	NULL
.	NULL

[	NULL
``	NULL
CJ-Acetyl	NULL
coenzyme	NULL
A	NULL
(	NULL
at	NULL
50-60	NULL
mCi/mmol	NULL
)	NULL
was	NULL
from	NULL
Amersham	NULL
International	NULL
(	NULL
Buckinghamshire	NULL
,	NULL
UK	NULL
)	NULL
.	NULL

Cells	NULL
and	NULL
Transfections	NULL
.	NULL

-	NULL
The	NULL
human	NULL
T	NULL
leukemia	NULL
,	NULL
Jurkat	NULL
,	NULL
and	NULL
the	NULL
murine	NULL
cells	NULL
EL4	NULL
were	NULL
maintained	NULL
in	NULL
RPMI	NULL
1640	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
heat-inactivated	NULL
FCS	NULL
.	NULL

Growth	NULL
was	NULL
at	NULL
37Â°C	NULL
and	NULL
humidified	NULL
in	NULL
5	NULL
%	NULL
CO2/95	NULL
%	NULL
air	NULL
.	NULL

Cells	NULL
were	NULL
transfected	NULL
via	NULL
elec-troporation	NULL
(	NULL
Gene	NULL
Pulser	NULL
;	NULL
Bio-Rad	NULL
Laboratories	NULL
,	NULL
UK	NULL
)	NULL
,	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

Briefly	NULL
,	NULL
Jurkat	NULL
cells	NULL
were	NULL
pulsed	NULL
(	NULL
2	NULL
x	NULL
10'/ml	NULL
)	NULL
in	NULL
media	NULL
+	NULL
serum	NULL
,	NULL
at	NULL
960	NULL
pF	NULL
and	NULL
310	NULL
V.	NULL
EL4	NULL
cells	NULL
(	NULL
supplemented	NULL
with	NULL
10	NULL
uM	NULL
B	NULL
@	NULL
-me	NULL
for	NULL
growth	NULL
)	NULL
,	NULL
at	NULL
10Â°/ml	NULL
,	NULL
were	NULL
pulsed	NULL
at	NULL
250	NULL
V	NULL
and	NULL
960	NULL
uF	NULL
.	NULL

Cultures	NULL
were	NULL
transfected	NULL
and	NULL
immediately	NULL
stimulated	NULL
,	NULL
as	NULL
necessary	NULL
,	NULL
for	NULL
24	NULL
h.	NULL
Plasmids	NULL
.	NULL

IL-2	NULL
chloramphenicol	NULL
acetyl	NULL
transferase	NULL
(	NULL
CAT	NULL
)	NULL
(	NULL
11	NULL
)	NULL
,	NULL
and	NULL
NFAT	NULL
CAT	NULL
(	NULL
5	NULL
)	NULL
have	NULL
been	NULL
previously	NULL
described	NULL
.	NULL

IL-2	NULL
CAT	NULL
contains	NULL
regulatory	NULL
sequences	NULL
upstream	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
(	NULL
from	NULL
-326	NULL
to	NULL
+47	NULL
)	NULL
,	NULL
that	NULL
include	NULL
the	NULL
IL-2	NULL
minimal	NULL
promoter	NULL
and	NULL
enhancer	NULL
,	NULL
directing	NULL
transcription	NULL
of	NULL
the	NULL
reporter	NULL
gene	NULL
.	NULL

NFAT	NULL
CAT	NULL
contains	NULL
three	NULL
copies	NULL
of	NULL
the	NULL
sequence	NULL
5Â°	NULL
GGAGGAAAAACTGTTT	NULL
CATACAGAAGGCGT	NULL
3	NULL
'	NULL
(	NULL
corresponding	NULL
to	NULL
the	NULL
sequence	NULL
from	NULL
position	NULL
-284	NULL
to	NULL
-258	NULL
relative	NULL
to	NULL
the	NULL
start	NULL
of	NULL
transcription	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
)	NULL
upstream	NULL
of	NULL
the	NULL
IL-2	NULL
minimal	NULL
promoter	NULL
driving	NULL
the	NULL
reporter	NULL
gene	NULL
CAT	NULL
.	NULL

This	NULL
sequence	NULL
has	NULL
been	NULL
identified	NULL
as	NULL
the	NULL
binding	NULL
site	NULL
for	NULL
NFAT	NULL
,	NULL
the	NULL
ARRE-2	NULL
site	NULL
of	NULL
the	NULL
human	NULL
IL-2	NULL
enhancer	NULL
(	NULL
3	NULL
)	NULL
.	NULL

IL-2	NULL
mpCAT	NULL
is	NULL
a	NULL
deletion	NULL
mutant	NULL
of	NULL
NFAT	NULL
CAT	NULL
in	NULL
which	NULL
the	NULL
binding	NULL
sites	NULL
for	NULL
NFAT	NULL
have	NULL
been	NULL
deleted	NULL
,	NULL
leaving	NULL
the	NULL
IL-2	NULL
minimal	NULL
promoter	NULL
to	NULL
drive	NULL
CAT	NULL
activity	NULL
.	NULL

The	NULL
sequence	NULL
of	NULL
the	NULL
IL-2	NULL
minimal	NULL
promoter	NULL
was	NULL
confirmed	NULL
by	NULL
ds	NULL
sequencing	NULL
(	NULL
Sequenase	NULL
,	NULL
version	NULL
2.0	NULL
;	NULL
United	NULL
States	NULL
Biochem	NULL
.	NULL

Corp.	NULL
,	NULL
Cleveland	NULL
,	NULL
OH	NULL
)	NULL
.	NULL

The	NULL
construct	NULL
used	NULL
for	NULL
the	NULL
expression	NULL
of	NULL
activated	NULL
Ras	NULL
was	NULL
created	NULL
by	NULL
inserting	NULL
the	NULL
0.7-kb	NULL
BamHI	NULL
fragment	NULL
of	NULL
CM	NULL
Vras	NULL
(	NULL
21	NULL
)	NULL
into	NULL
the	NULL
BamHI	NULL
site	NULL
of	NULL
pEF	NULL
BOS	NULL
(	NULL
28	NULL
)	NULL
.	NULL

Orientation	NULL
was	NULL
determined	NULL
by	NULL
restriction	NULL
analysis	NULL
and	NULL
activity	NULL
was	NULL
assessed	NULL
in	NULL
a	NULL
focus	NULL
forming	NULL
assay	NULL
.	NULL

CNA	NULL
and	NULL
CNB	NULL
have	NULL
been	NULL
described	NULL
(	NULL
22	NULL
)	NULL
,	NULL
and	NULL
are	NULL
expressed	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
SRa	NULL
promoter	NULL
of	NULL
HTLV-1	NULL
(	NULL
23	NULL
)	NULL
.	NULL

CNM	NULL
is	NULL
a	NULL
truncation	NULL
of	NULL
in	NULL
which	NULL
a	NULL
stop	NULL
codon	NULL
has	NULL
been	NULL
introduced	NULL
at	NULL
22397	NULL
,	NULL
resulting	NULL
in	NULL
a	NULL
constitutively	NULL
active	NULL
,	NULL
Ca**-independent	NULL
phosphatase	NULL
(	NULL
29	NULL
)	NULL
.	NULL

CAT	NULL
Assays	NULL
.	NULL

-	NULL
Assays	NULL
were	NULL
performed	NULL
according	NULL
to	NULL
the	NULL
method	NULL
of	NULL
Sleigh	NULL
et	NULL
al	NULL
.	NULL

(	NULL
30	NULL
)	NULL
,	NULL
with	NULL
modifications	NULL
.	NULL

Briefly	NULL
,	NULL
cells	NULL
were	NULL
lysed	NULL
in	NULL
100	NULL
ul	NULL
of	NULL
0.65	NULL
%	NULL
NP-40	NULL
,	NULL
10	NULL
mM	NULL
Tris	NULL
,	NULL
pH	NULL
8.0	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
150	NULL
mM	NULL
NaCl	NULL
,	NULL
for	NULL
10	NULL
min	NULL
on	NULL
ice	NULL
.	NULL

Cellular	NULL
debris	NULL
was	NULL
pelleted	NULL
,	NULL
and	NULL
the	NULL
lysate	NULL
heat	NULL
was	NULL
treated	NULL
at	NULL
68Â°C	NULL
for	NULL
10	NULL
min	NULL
before	NULL
use	NULL
.	NULL

Assay	NULL
conditions	NULL
were	NULL
150	NULL
mMTris	NULL
,	NULL
pH	NULL
8.0	NULL
,	NULL
0.05	NULL
uCi	NULL
[	NULL
``	NULL
``	NULL
CJacetyl	NULL
coenzyme	NULL
A	NULL
,	NULL
and	NULL
2	NULL
mM	NULL
chloramphenicol	NULL
.	NULL

Chloramphenicols	NULL
were	NULL
extracted	NULL
with	NULL
ethyl	NULL
acetate	NULL
,	NULL
and	NULL
the	NULL
amount	NULL
of	NULL
radioactivity	NULL
in	NULL
the	NULL
acetylated	NULL
products	NULL
and	NULL
nonacetylated	NULL
substrate	NULL
of	NULL
each	NULL
reaction	NULL
was	NULL
determined	NULL
by	NULL
liquid	NULL
scintillation	NULL
counting	NULL
of	NULL
organic	NULL
and	NULL
aqueous	NULL
phases	NULL
,	NULL
respectively	NULL
.	NULL

Results	NULL
A	NULL
Constitutively	NULL
Active	NULL
Mutant	NULL
of	NULL
Calcineurin	NULL
Synergizes	NULL
with	NULL
Phorbol	NULL
Esters	NULL
to	NULL
Regulate	NULL
NFAT	NULL
.	NULL

-	NULL
'To	NULL
monitor	NULL
NFAT	NULL
activity	NULL
,	NULL
we	NULL
employed	NULL
transient	NULL
transfection	NULL
and	NULL
quantitation	NULL
of	NULL
the	NULL
expression	NULL
of	NULL
a	NULL
CAT	NULL
reporter	NULL
gene	NULL
whose	NULL
activity	NULL
is	NULL
regulated	NULL
by	NULL
a	NULL
trimer	NULL
of	NULL
the	NULL
NFAT	NULL
binding	NULL
site	NULL
,	NULL
located	NULL
upstream	NULL
of	NULL
the	NULL
IL-2	NULL
minimal	NULL
promoter	NULL
.	NULL

The	NULL
signaling	NULL
requirements	NULL
for	NULL
expression	NULL
of	NULL
this	NULL
transfected	NULL
NFAT	NULL
reporter	NULL
gene	NULL
in	NULL
Jurkat	NULL
cells	NULL
have	NULL
been	NULL
described	NULL
(	NULL
3	NULL
,	NULL
6	NULL
,	NULL
13	NULL
)	NULL
.	NULL

Ionomycin	NULL
,	NULL
which	NULL
elevates	NULL
intracellular	NULL
calcium	NULL
,	NULL
and	NULL
Pdbu	NULL
,	NULL
which	NULL
activates	NULL
PKC	NULL
,	NULL
synergize	NULL
for	NULL
maximal	NULL
NFAT	NULL
induction	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
a	NULL
)	NULL
.	NULL

To	NULL
examine	NULL
the	NULL
effect	NULL
of	NULL
calcineurin	NULL
on	NULL
NFAT	NULL
,	NULL
Jurkat	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
NFAT	NULL
CAT	NULL
plus	NULL
one	NULL
or	NULL
a	NULL
combination	NULL
of	NULL
calcineurin	NULL
expression	NULL
constructs	NULL
:	NULL
CNA	NULL
4	NULL
,	NULL
the	NULL
wild	NULL
type	NULL
catalytic	NULL
subunit	NULL
of	NULL
calcineurin	NULL
(	NULL
CNA	NULL
)	NULL
;	NULL
a	NULL
wild	NULL
type	NULL
calcineurin	NULL
B	NULL
subunit	NULL
(	NULL
CNB	NULL
)	NULL
,	NULL
or	NULL
the	NULL
constitutively	NULL
active	NULL
calcineurin	NULL
A	NULL
mutant	NULL
(	NULL
CNM	NULL
)	NULL
.	NULL

The	NULL
latter	NULL
is	NULL
a	NULL
deletion	NULL
mutant	NULL
of	NULL
the	NULL
calcineurin	NULL
catalytic	NULL
subunit	NULL
,	NULL
calcineurin	NULL
A4	NULL
,	NULL
that	NULL
lacks	NULL
functional	NULL
calmodulin	NULL
binding	NULL
and	NULL
autoinhibitory	NULL
do-mains	NULL
,	NULL
and	NULL
has	NULL
Ca**-independent	NULL
constitutive	NULL
phosphatase	NULL
activity	NULL
in	NULL
vitro	NULL
(	NULL
29	NULL
)	NULL
.	NULL

The	NULL
data	NULL
show	NULL
that	NULL
expression	NULL
of	NULL
wild	NULL
type	NULL
CNA	NULL
and	NULL
CNB	NULL
either	NULL
alone	NULL
or	NULL
in	NULL
combination	NULL
does	NULL
not	NULL
induce	NULL
a	NULL
marked	NULL
activation	NULL
of	NULL
NFAT	NULL
CAT	NULL
.	NULL

As	NULL
described	NULL
previously	NULL
,	NULL
ionomycin	NULL
alone	NULL
has	NULL
a	NULL
slight	NULL
stimulatory	NULL
effect	NULL
that	NULL
is	NULL
enhanced	NULL
in	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
combination	NULL
of	NULL
CNA	NULL
and	NULL
CNB	NULL
(	NULL
23	NULL
)	NULL
.	NULL

PdBu	NULL
alone	NULL
has	NULL
no	NULL
apparent	NULL
stimulatory	NULL
effect	NULL
,	NULL
but	NULL
the	NULL
most	NULL
striking	NULL
observation	NULL
was	NULL
the	NULL
strong	NULL
synergy	NULL
between	NULL
the	NULL
CNM	NULL
and	NULL
Pdbu	NULL
that	NULL
resulted	NULL
in	NULL
a	NULL
level	NULL
of	NULL
NFAT	NULL
induction	NULL
com	NULL
1518	NULL
Ras	NULL
and	NULL
Calcineurin	NULL
Regulate	NULL
NFAT	NULL
80	NULL
oC	NULL
(	NULL
J	NULL
control	NULL
a	NULL
â	NULL
;	NULL
A	NULL
CNA	NULL
U	NULL
so-	NULL
CNB	NULL
E	NULL
AC	NULL
CNA+CNB	NULL
L2	NULL
H	NULL
CNM	NULL
R	NULL
CQ	NULL
iono+PdBu	NULL
a-	NULL
401	NULL
0	NULL
C	NULL
d	NULL
a	NULL
6	NULL
20	NULL
``	NULL
&	NULL
th	NULL
stimuli	NULL
b	NULL
C	NULL
ctl	NULL
p	NULL
4.51	NULL
M	NULL
pdbu	NULL
<	NULL
U	NULL
<	NULL
Â£	NULL
2	NULL
2.57	NULL
G	NULL
3	NULL
``	NULL
C	NULL
.A	NULL
``	NULL
d	NULL
8	NULL
0.57	NULL
ctl	NULL
cnm	NULL
Figure	NULL
1	NULL
.	NULL

Constitutively	NULL
activated	NULL
calcineurin	NULL
synergizes	NULL
with	NULL
phorbol	NULL
ester	NULL
to	NULL
regulate	NULL
NFAT	NULL
transcriptional	NULL
activity	NULL
.	NULL

(	NULL
a	NULL
)	NULL
Jurkat	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
NFAT	NULL
CAT	NULL
and	NULL
calcineurin	NULL
expression	NULL
vectors	NULL
either	NULL
alone	NULL
,	NULL
or	NULL
in	NULL
combination	NULL
was	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Ionomycin	NULL
was	NULL
used	NULL
at	NULL
0.5	NULL
ug/ml	NULL
and	NULL
PdBu	NULL
at	NULL
50	NULL
ng/ml	NULL
,	NULL
as	NULL
indicated	NULL
.	NULL

Here	NULL
,	NULL
10	NULL
ug	NULL
of	NULL
reporter	NULL
construct	NULL
was	NULL
used	NULL
in	NULL
concert	NULL
with	NULL
10	NULL
ug	NULL
of	NULL
each	NULL
calcineurin	NULL
construct	NULL
.	NULL

Cells	NULL
were	NULL
electroporated	NULL
and	NULL
stimulated	NULL
immediately	NULL
after	NULL
transfection	NULL
for	NULL
24	NULL
h	NULL
before	NULL
cytosolic	NULL
extracts	NULL
were	NULL
made	NULL
and	NULL
reporter	NULL
gene	NULL
activity	NULL
was	NULL
assessed	NULL
.	NULL

Percent	NULL
conversion	NULL
represents	NULL
the	NULL
ratio	NULL
of	NULL
radioactivity	NULL
extracted	NULL
in	NULL
the	NULL
organic	NULL
phase	NULL
vs.	NULL
total	NULL
radioactivity	NULL
in	NULL
organic	NULL
plus	NULL
aqueous	NULL
phases	NULL
.	NULL

(	NULL
D	NULL
]	NULL
)	NULL
control	NULL
-	NULL
NFAT	NULL
CAT	NULL
alone	NULL
;	NULL
(	NULL
2	NULL
)	NULL
CNA	NULL
-	NULL
NFAT	NULL
CAT	NULL
+	NULL
10	NULL
ug	NULL
wt	NULL
CNA	NULL
;	NULL
(	NULL
2	NULL
)	NULL
CNB	NULL
-	NULL
NFAT	NULL
CAT	NULL
+	NULL
10	NULL
ug	NULL
wt	NULL
CNB	NULL
;	NULL
(	NULL
@	NULL
)	NULL
CNA	NULL
+	NULL
CNB	NULL
-	NULL
NFAT	NULL
CAT	NULL
+	NULL
10	NULL
ug	NULL
wt	NULL
CNA	NULL
+	NULL
10	NULL
ug	NULL
wt	NULL
CNB	NULL
;	NULL
(	NULL
N	NULL
)	NULL
CNM	NULL
-	NULL
NFAT	NULL
CAT	NULL
+	NULL
10	NULL
ug	NULL
CNM	NULL
.	NULL

The	NULL
data	NULL
shown	NULL
are	NULL
representative	NULL
of	NULL
more	NULL
than	NULL
five	NULL
experiments	NULL
.	NULL

Percent	NULL
conversion	NULL
in	NULL
control	NULL
unstimulated	NULL
samples	NULL
ranged	NULL
from	NULL
2.4	NULL
to	NULL
7.7	NULL
%	NULL
.	NULL

(	NULL
5	NULL
)	NULL
Jurkat	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
2	NULL
ug	NULL
of	NULL
AP-1	NULL
CAT	NULL
and	NULL
20	NULL
ug	NULL
of	NULL
CNM	NULL
or	NULL
not	NULL
(	NULL
control	NULL
)	NULL
.	NULL

(	NULL
@	NULL
)	NULL
=	NULL
control	NULL
unstimulated	NULL
cells	NULL
;	NULL
(	NULL
MW	NULL
)	NULL
=	NULL
Pdbu	NULL
50	NULL
ng/ml	NULL
.	NULL

Fold	NULL
induction	NULL
is	NULL
the	NULL
ratio	NULL
of	NULL
activity	NULL
(	NULL
%	NULL
conversion	NULL
)	NULL
in	NULL
stimulated	NULL
cells	NULL
vs.	NULL
control	NULL
unstimulated	NULL
cell	NULL
(	NULL
no	NULL
added	NULL
CNM	NULL
)	NULL
.	NULL

The	NULL
data	NULL
shown	NULL
are	NULL
representative	NULL
of	NULL
three	NULL
experiments	NULL
.	NULL

Percent	NULL
conversion	NULL
in	NULL
control	NULL
unstimulated	NULL
cells	NULL
ranged	NULL
from	NULL
1.0	NULL
to	NULL
5.9	NULL
%	NULL
.	NULL

parable	NULL
to	NULL
that	NULL
observed	NULL
in	NULL
response	NULL
to	NULL
ionomycin	NULL
plus	NULL
Pdbu	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
a	NULL
)	NULL
.	NULL

These	NULL
data	NULL
indicate	NULL
that	NULL
the	NULL
CNM	NULL
but	NULL
not	NULL
wild	NULL
type	NULL
CNA	NULL
or	NULL
CNB	NULL
can	NULL
substitute	NULL
for	NULL
ionomycin-induced	NULL
calcium	NULL
signals	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
NFAT	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
the	NULL
CNM	NULL
on	NULL
NFAT	NULL
activity	NULL
was	NULL
selective	NULL
as	NULL
judged	NULL
by	NULL
two	NULL
independent	NULL
observations	NULL
.	NULL

First	NULL
,	NULL
the	NULL
CNM	NULL
did	NULL
not	NULL
enhance	NULL
expression	NULL
of	NULL
a	NULL
CAT	NULL
reporter	NULL
gene	NULL
driven	NULL
by	NULL
the	NULL
IL-2	NULL
minimal	NULL
promoter	NULL
alone	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Second	NULL
,	NULL
the	NULL
CNM	NULL
had	NULL
no	NULL
1519	NULL
Woodrow	NULL
et	NULL
al	NULL
.	NULL

effect	NULL
on	NULL
the	NULL
PKC	NULL
inducibility	NULL
of	NULL
an	NULL
AP-1	NULL
reporter	NULL
construct	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
b	NULL
)	NULL
.	NULL

v-Ha-ras	NULL
Synergizes	NULL
with	NULL
Calcium	NULL
Ionophore	NULL
to	NULL
Regulate	NULL
NFAT	NULL
CAT	NULL
in	NULL
Jurkat	NULL
Cells	NULL
.	NULL

-	NULL
p21	NULL
'	NULL
``	NULL
*	NULL
``	NULL
is	NULL
mutated	NULL
at	NULL
codon	NULL
12	NULL
and	NULL
59	NULL
(	NULL
31	NULL
)	NULL
.	NULL

These	NULL
mutations	NULL
render	NULL
the	NULL
Ras	NULL
proteins	NULL
insensitive	NULL
to	NULL
the	NULL
Ras-GTPase	NULL
activating	NULL
proteins	NULL
such	NULL
that	NULL
the	NULL
Ras	NULL
accumulates	NULL
in	NULL
cells	NULL
in	NULL
an	NULL
``	NULL
active	NULL
``	NULL
GTP-bound	NULL
state	NULL
(	NULL
32	NULL
)	NULL
.	NULL

When	NULL
expressed	NULL
in	NULL
the	NULL
murine	NULL
thymoma	NULL
EL4	NULL
,	NULL
signals	NULL
generated	NULL
by	NULL
p21	NULL
``	NULL
``	NULL
***	NULL
synergized	NULL
with	NULL
either	NULL
the	NULL
calcium	NULL
ionophore	NULL
ionomycin	NULL
or	NULL
the	NULL
PKC	NULL
activator	NULL
Pdbu	NULL
to	NULL
induce	NULL
NFAT	NULL
(	NULL
21	NULL
)	NULL
.	NULL

The	NULL
Jurkat	NULL
cells	NULL
used	NULL
in	NULL
the	NULL
present	NULL
study	NULL
differ	NULL
from	NULL
EL4	NULL
cells	NULL
in	NULL
their	NULL
activation	NULL
response	NULL
to	NULL
Pdbu	NULL
(	NULL
33	NULL
)	NULL
.	NULL

Hence	NULL
in	NULL
EL4	NULL
cells	NULL
,	NULL
PKC	NULL
activation	NULL
alone	NULL
is	NULL
sufficient	NULL
for	NULL
NFAT	NULL
activity	NULL
,	NULL
whereas	NULL
in	NULL
Jurkat	NULL
cells	NULL
there	NULL
is	NULL
an	NULL
apparent	NULL
obligatory	NULL
requirement	NULL
for	NULL
calcium	NULL
signals	NULL
for	NULL
NFAT	NULL
induction	NULL
(	NULL
11	NULL
)	NULL
.	NULL

The	NULL
data	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
a	NULL
show	NULL
the	NULL
characteristics	NULL
of	NULL
NFAT	NULL
regulation	NULL
in	NULL
Jurkat	NULL
cells	NULL
cotransfected	NULL
with	NULL
NFAT	NULL
CAT	NULL
and	NULL
p21v4*	NULL
,	NULL
The	NULL
mutationally	NULL
activated	NULL
Ras	NULL
alone	NULL
had	NULL
a	NULL
stimulatory	NULL
effect	NULL
on	NULL
NFAT	NULL
that	NULL
was	NULL
not	NULL
further	NULL
enhanced	NULL
by	NULL
PdBu	NULL
treatment	NULL
of	NULL
the	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
p21	NULL
``	NULL
generated	NULL
a	NULL
strong	NULL
synergy	NULL
with	NULL
ionomycin	NULL
to	NULL
induce	NULL
levels	NULL
of	NULL
NFAT	NULL
comparable	NULL
to	NULL
that	NULL
seen	NULL
in	NULL
ionomycin	NULL
and	NULL
PdBu-treated	NULL
cells	NULL
The	NULL
fact	NULL
that	NULL
p21	NULL
``	NULL
alone	NULL
only	NULL
elicits	NULL
a	NULL
weak	NULL
stimulation	NULL
of	NULL
NFAT	NULL
CAT	NULL
a	NULL
a	NULL
U	NULL
Â§	NULL
Â»	NULL
a	NULL
$	NULL
|	NULL
boa	NULL
P	NULL
30	NULL
%	NULL
J	NULL
&	NULL
Â»	NULL
|	NULL
;	NULL
W	NULL
9	NULL
P	NULL
I	NULL
[	NULL
|	NULL
``	NULL
_	NULL
|	NULL
PPAS	NULL
|	NULL
control	NULL
v-Ha-ras	NULL
CJ	NULL
control	NULL
&	NULL
E	NULL
P4Bu	NULL
U	NULL
E	NULL
m	NULL
none	NULL
v-Ha-ras	NULL
Figure	NULL
2	NULL
.	NULL

-	NULL
v-Ha-ras	NULL
regulates	NULL
NFAT	NULL
CAT	NULL
and	NULL
AP-1	NULL
CAT	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

(	NULL
a	NULL
)	NULL
Jurkat	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
10	NULL
ug	NULL
NFAT	NULL
CAT	NULL
,	NULL
and	NULL
40	NULL
ug	NULL
of	NULL
EF	NULL
empty	NULL
vector	NULL
(	NULL
control	NULL
)	NULL
or	NULL
EF	NULL
v-Ha-ras	NULL
(	NULL
v-Ha-ras	NULL
)	NULL
.	NULL

Stimulation	NULL
was	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
:	NULL
(	NULL
0	NULL
)	NULL
unstimulated	NULL
,	NULL
(	NULL
@	NULL
)	NULL
iono	NULL
,	NULL
(	NULL
Â¥	NULL
)	NULL
Pdbu	NULL
,	NULL
(	NULL
&	NULL
)	NULL
iono	NULL
+	NULL
Pdbu	NULL
.	NULL

Activity	NULL
was	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

The	NULL
data	NULL
shown	NULL
are	NULL
representative	NULL
of	NULL
three	NULL
experiments	NULL
.	NULL

Percent	NULL
conversion	NULL
in	NULL
control	NULL
unstimulated	NULL
samples	NULL
as	NULL
per	NULL
Fig	NULL
.	NULL

1	NULL
a	NULL
.	NULL

(	NULL
b	NULL
)	NULL
Jurkat	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
2	NULL
ug	NULL
of	NULL
AP-1	NULL
CAT	NULL
and	NULL
20	NULL
ug	NULL
of	NULL
EF	NULL
empty	NULL
(	NULL
control	NULL
)	NULL
or	NULL
20	NULL
ug	NULL
EF	NULL
v-Ha-ras	NULL
(	NULL
v-Ha-ras	NULL
)	NULL
.	NULL

Stimulation	NULL
,	NULL
(	NULL
F	NULL
)	NULL
control	NULL
,	NULL
unstimulated	NULL
or	NULL
(	NULL
BW	NULL
)	NULL
PdBu	NULL
treated	NULL
,	NULL
and	NULL
activity	NULL
are	NULL
as	NULL
described	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

The	NULL
data	NULL
shown	NULL
are	NULL
representative	NULL
of	NULL
four	NULL
experiments	NULL
.	NULL

Percent	NULL
conversion	NULL
in	NULL
control	NULL
unstimulated	NULL
samples	NULL
ranged	NULL
from	NULL
1.2	NULL
to	NULL
5.9	NULL
%	NULL
.	NULL

and	NULL
also	NULL
that	NULL
Ras	NULL
does	NULL
not	NULL
synergize	NULL
with	NULL
PdBu	NULL
was	NULL
not	NULL
due	NULL
to	NULL
insufficient	NULL
expression	NULL
of	NULL
Ras	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
level	NULL
of	NULL
p21	NULL
``	NULL
'	NULL
``	NULL
**	NULL
expressed	NULL
in	NULL
these	NULL
experiments	NULL
was	NULL
alone	NULL
sufficient	NULL
to	NULL
stimulate	NULL
maximal	NULL
levels	NULL
of	NULL
AP-1	NULL
activity	NULL
,	NULL
i.e	NULL
.	NULL

,	NULL
comparable	NULL
to	NULL
the	NULL
level	NULL
of	NULL
AP-1	NULL
activity	NULL
induced	NULL
in	NULL
response	NULL
to	NULL
PKC	NULL
stimulation	NULL
with	NULL
phorbol	NULL
ester	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
b	NULL
)	NULL
.	NULL

Cakineurin	NULL
and	NULL
p21	NULL
``	NULL
``	NULL
Synergize	NULL
to	NULL
Regulate	NULL
NFAT	NULL
.	NULL

p21	NULL
``	NULL
``	NULL
*=	NULL
and	NULL
CNM	NULL
can	NULL
both	NULL
generate	NULL
signals	NULL
that	NULL
regulate	NULL
NFAT	NULL
,	NULL
but	NULL
these	NULL
signals	NULL
appear	NULL
to	NULL
differ	NULL
.	NULL

CNM	NULL
synergizes	NULL
with	NULL
PKC	NULL
,	NULL
but	NULL
not	NULL
calcium	NULL
controlled	NULL
signals	NULL
to	NULL
regulate	NULL
NFAT	NULL
,	NULL
whereas	NULL
p21	NULL
``	NULL
``	NULL
*	NULL
has	NULL
the	NULL
converse	NULL
ability	NULL
to	NULL
synergize	NULL
with	NULL
calcium	NULL
,	NULL
but	NULL
not	NULL
PKC-controlled	NULL
pathways	NULL
.	NULL

To	NULL
examine	NULL
the	NULL
potential	NULL
for	NULL
p21	NULL
``	NULL
and	NULL
calcineurin	NULL
to	NULL
synergize	NULL
in	NULL
NFAT	NULL
induction	NULL
,	NULL
Jurkat	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
NFAT	NULL
CAT	NULL
and	NULL
p21	NULL
``	NULL
and	NULL
CNM	NULL
,	NULL
either	NULL
alone	NULL
or	NULL
in	NULL
combination	NULL
.	NULL

Data	NULL
averaged	NULL
from	NULL
four	NULL
experiments	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
show	NULL
that	NULL
p21	NULL
``	NULL
'*=	NULL
in	NULL
combination	NULL
with	NULL
CNM	NULL
induced	NULL
a	NULL
strong	NULL
expression	NULL
of	NULL
NFAT	NULL
comparable	NULL
to	NULL
that	NULL
seen	NULL
in	NULL
response	NULL
to	NULL
either	NULL
plus	NULL
ionomycin	NULL
or	NULL
CNM	NULL
plus	NULL
Pdbu	NULL
.	NULL

Both	NULL
p21	NULL
``	NULL
and	NULL
calcineurin	NULL
are	NULL
activated	NULL
in	NULL
response	NULL
to	NULL
triggering	NULL
of	NULL
the	NULL
TCR	NULL
(	NULL
15	NULL
,	NULL
24	NULL
,	NULL
25	NULL
)	NULL
.	NULL

The	NULL
data	NULL
show	NULL
that	NULL
p21	NULL
``	NULL
``	NULL
*	NULL
plus	NULL
CNM	NULL
also	NULL
induced	NULL
NFAT	NULL
CAT	NULL
to	NULL
a	NULL
level	NULL
greater	NULL
than	NULL
that	NULL
induced	NULL
in	NULL
response	NULL
to	NULL
TCR	NULL
triggering	NULL
with	NULL
the	NULL
CD3	NULL
antibody	NULL
UCHT1	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

The	NULL
regulatory	NULL
effect	NULL
of	NULL
p21	NULL
``	NULL
*	NULL
``	NULL
**	NULL
on	NULL
NFAT	NULL
is	NULL
not	NULL
confined	NULL
to	NULL
Jurkat	NULL
cells	NULL
but	NULL
also	NULL
occurs	NULL
in	NULL
a	NULL
murine	NULL
T	NULL
cell	NULL
EL4	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
calcineurin	NULL
mutants	NULL
on	NULL
NFAT	NULL
expression	NULL
in	NULL
cells	NULL
other	NULL
than	NULL
Jurkat	NULL
has	NULL
not	NULL
been	NULL
explored	NULL
in	NULL
previous	NULL
studies	NULL
.	NULL

The	NULL
data	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
show	NULL
that	NULL
in	NULL
EL4	NULL
cells	NULL
expression	NULL
of	NULL
CNM	NULL
but	NULL
not	NULL
wild	NULL
type	NULL
CNA	NULL
or	NULL
CNB	NULL
can	NULL
synergize	NULL
with	NULL
Pdbu	NULL
or	NULL
p21	NULL
``	NULL
``	NULL
**	NULL
to	NULL
induce	NULL
NFAT	NULL
.	NULL

Expression	NULL
of	NULL
CNM	NULL
alone	NULL
induced	NULL
only	NULL
a	NULL
weak	NULL
NFAT	NULL
response	NULL
,	NULL
but	NULL
in	NULL
combination	NULL
with	NULL
Pdbu	NULL
or	NULL
with	NULL
the	NULL
constitutively	NULL
active	NULL
Ras	NULL
,	NULL
the	NULL
S	NULL
1007	NULL
7	NULL
``	NULL
Â§	NULL
m	NULL
4	NULL
Z	NULL
.	NULL

$	NULL
Â®	NULL
&	NULL
$	NULL
w	NULL
#	NULL
E	NULL
Ã©	NULL
201	NULL
%	NULL
7	NULL
$	NULL
3	NULL
FZ22	NULL
Â°	NULL
og	NULL
g	NULL
&	NULL
s	NULL
g	NULL
f	NULL
control	NULL
ras+iono	NULL
cam+pdbu	NULL
cnm+ras	NULL
iono+pdbu	NULL
Figure	NULL
3	NULL
.	NULL

-	NULL
Calcineurin	NULL
synergizes	NULL
with	NULL
v-Ha-ras	NULL
to	NULL
regulate	NULL
NFAT	NULL
CAT	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

Jurkat	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
10	NULL
ug	NULL
NFAT	NULL
CAT	NULL
plus	NULL
10	NULL
ug	NULL
of	NULL
v-Ha-ras	NULL
or	NULL
CNM	NULL
or	NULL
both	NULL
,	NULL
as	NULL
indicated	NULL
.	NULL

Stimuli	NULL
are	NULL
as	NULL
indicated	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
;	NULL
in	NULL
addition	NULL
,	NULL
UCHT1	NULL
(	NULL
10	NULL
ug/ml	NULL
in	NULL
culture	NULL
)	NULL
was	NULL
added	NULL
as	NULL
indicated	NULL
.	NULL

Percent	NULL
maximum	NULL
response	NULL
represents	NULL
the	NULL
ratio	NULL
of	NULL
activity	NULL
seen	NULL
in	NULL
samples	NULL
vs.	NULL
that	NULL
in	NULL
iono	NULL
+	NULL
Pdbu-treated	NULL
cultures	NULL
without	NULL
added	NULL
v-Ha-ras	NULL
or	NULL
CNM	NULL
(	NULL
mean	NULL
iono	NULL
+	NULL
pdbu	NULL
=	NULL
84.5	NULL
+	NULL
0.6	NULL
%	NULL
)	NULL
.	NULL

Data	NULL
are	NULL
the	NULL
mean	NULL
from	NULL
four	NULL
experiments	NULL
,	NULL
error	NULL
bars	NULL
represent	NULL
SEM	NULL
.	NULL

Percent	NULL
conversion	NULL
in	NULL
control	NULL
unstimulated	NULL
samples	NULL
as	NULL
per	NULL
Fig	NULL
.	NULL

1	NULL
a	NULL
.	NULL

1520	NULL
30	NULL
[	NULL
]	NULL
control	NULL
%	NULL
conversion	NULL
-	NULL
NFAT	NULL
CAT	NULL
Figure	NULL
4	NULL
.	NULL

-	NULL
Calcineurin	NULL
synergizes	NULL
with	NULL
vHa-ras	NULL
to	NULL
regulate	NULL
NFAT	NULL
CAT	NULL
in	NULL
EL4	NULL
cells	NULL
.	NULL

EL4	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
20	NULL
ug	NULL
of	NULL
NFAT	NULL
CAT	NULL
and	NULL
50	NULL
ug	NULL
of	NULL
either	NULL
(	NULL
]	NULL
)	NULL
EF	NULL
empty	NULL
,	NULL
(	NULL
@	NULL
)	NULL
CNA	NULL
,	NULL
(	NULL
&	NULL
)	NULL
CNB	NULL
,	NULL
or	NULL
(	NULL
Bl	NULL
)	NULL
CNM	NULL
,	NULL
as	NULL
indicated	NULL
.	NULL

Stimuli	NULL
were	NULL
applied	NULL
and	NULL
data	NULL
are	NULL
represented	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

The	NULL
figure	NULL
is	NULL
representative	NULL
of	NULL
two	NULL
experiments	NULL
.	NULL

active	NULL
calcineurin	NULL
mutant	NULL
synergized	NULL
to	NULL
induce	NULL
a	NULL
level	NULL
of	NULL
NFAT	NULL
activity	NULL
similar	NULL
to	NULL
that	NULL
induced	NULL
in	NULL
response	NULL
to	NULL
cell	NULL
activation	NULL
by	NULL
ionomycin	NULL
in	NULL
combination	NULL
with	NULL
Pdbu	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

Discussion	NULL
In	NULL
T	NULL
lymphocytes	NULL
,	NULL
p21	NULL
``	NULL
is	NULL
stimulated	NULL
via	NULL
the	NULL
TCR	NULL
in	NULL
a	NULL
mechanism	NULL
involving	NULL
TCR	NULL
inhibition	NULL
of	NULL
ras	NULL
GT	NULL
Pase-activating	NULL
proteins	NULL
(	NULL
ras-GAPs	NULL
)	NULL
(	NULL
15	NULL
,	NULL
18	NULL
)	NULL
.	NULL

One	NULL
important	NULL
role	NULL
for	NULL
the	NULL
TCR	NULL
is	NULL
to	NULL
control	NULL
the	NULL
expression	NULL
and	NULL
function	NULL
of	NULL
transcription	NULL
factors	NULL
such	NULL
as	NULL
NFAT	NULL
,	NULL
that	NULL
contribute	NULL
to	NULL
the	NULL
control	NULL
of	NULL
IL-2	NULL
gene	NULL
transcription	NULL
(	NULL
6	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
a	NULL
mutated	NULL
constitutively	NULL
activated	NULL
p21	NULL
``	NULL
induces	NULL
a	NULL
response	NULL
in	NULL
T	NULL
cells	NULL
that	NULL
can	NULL
synergize	NULL
with	NULL
a	NULL
calcium	NULL
signal	NULL
to	NULL
modulate	NULL
T	NULL
cell	NULL
activation	NULL
as	NULL
judged	NULL
by	NULL
NFAT	NULL
induction	NULL
(	NULL
21	NULL
,	NULL
34	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
overexpression	NULL
of	NULL
two	NULL
src-family	NULL
kinases	NULL
,	NULL
p56	NULL
and	NULL
p595Â®	NULL
,	NULL
appear	NULL
to	NULL
be	NULL
able	NULL
to	NULL
partially	NULL
replace	NULL
the	NULL
calcium	NULL
requirement	NULL
for	NULL
induction	NULL
of	NULL
NFAT	NULL
-directed	NULL
transcription	NULL
(	NULL
35	NULL
,	NULL
36	NULL
)	NULL
.	NULL

The	NULL
components	NULL
of	NULL
the	NULL
calcium	NULL
signaling	NULL
pathway	NULL
able	NULL
to	NULL
cooperate	NULL
with	NULL
p21	NULL
``	NULL
Â®	NULL
in	NULL
T	NULL
cells	NULL
to	NULL
regulate	NULL
NFAT	NULL
have	NULL
not	NULL
been	NULL
previously	NULL
determined	NULL
.	NULL

However	NULL
,	NULL
recent	NULL
studies	NULL
have	NULL
established	NULL
that	NULL
calcineurin	NULL
,	NULL
which	NULL
is	NULL
regulated	NULL
by	NULL
increases	NULL
in	NULL
cytosolic	NULL
calcium	NULL
,	NULL
is	NULL
essential	NULL
for	NULL
TCR	NULL
signaling	NULL
function	NULL
(	NULL
22	NULL
,	NULL
23	NULL
,	NULL
37	NULL
)	NULL
.	NULL

The	NULL
data	NULL
presented	NULL
here	NULL
show	NULL
that	NULL
expression	NULL
of	NULL
a	NULL
truncated	NULL
,	NULL
constitutively	NULL
active	NULL
calcineurin	NULL
in	NULL
both	NULL
a	NULL
human	NULL
leukemic	NULL
T	NULL
cell	NULL
line	NULL
,	NULL
Jurkat	NULL
,	NULL
and	NULL
in	NULL
the	NULL
murine	NULL
thymoma	NULL
,	NULL
EL4	NULL
,	NULL
can	NULL
substitute	NULL
for	NULL
calcium	NULL
signals	NULL
and	NULL
,	NULL
in	NULL
synergy	NULL
with	NULL
an	NULL
activated	NULL
p21	NULL
``	NULL
,	NULL
stimulate	NULL
T	NULL
cells	NULL
to	NULL
induce	NULL
NFAT	NULL
-mediated	NULL
transcription	NULL
.	NULL

Previous	NULL
studies	NULL
have	NULL
indicated	NULL
that	NULL
calcineurin	NULL
can	NULL
synergize	NULL
with	NULL
phorbol	NULL
esters	NULL
to	NULL
induce	NULL
NFAT	NULL
and	NULL
hence	NULL
the	NULL
IL-2	NULL
gene	NULL
(	NULL
22	NULL
,	NULL
23	NULL
)	NULL
.	NULL

The	NULL
current	NULL
study	NULL
identifies	NULL
p21	NULL
``	NULL
as	NULL
an	NULL
alternative	NULL
partner	NULL
for	NULL
calcineurin	NULL
in	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

NFAT	NULL
is	NULL
known	NULL
to	NULL
have	NULL
a	NULL
critical	NULL
function	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
(	NULL
11	NULL
,	NULL
21	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
exact	NULL
composition	NULL
of	NULL
this	NULL
transcriptional	NULL
factor	NULL
is	NULL
as	NULL
yet	NULL
unresolved	NULL
.	NULL

It	NULL
is	NULL
proposed	NULL
that	NULL
NFAT	NULL
is	NULL
a	NULL
complex	NULL
of	NULL
at	NULL
least	NULL
two	NULL
compo-nents	NULL
:	NULL
a	NULL
T	NULL
cell-specific	NULL
cytosolic	NULL
component	NULL
that	NULL
translocates	NULL
to	NULL
the	NULL
nucleus	NULL
in	NULL
response	NULL
to	NULL
increases	NULL
in	NULL
cytosolic	NULL
calcium	NULL
,	NULL
and	NULL
a	NULL
nuclear	NULL
component	NULL
,	NULL
expressed	NULL
only	NULL
in	NULL
activated	NULL
cells	NULL
,	NULL
Ras	NULL
and	NULL
Calcineurin	NULL
Regulate	NULL
NFAT	NULL
that	NULL
appears	NULL
to	NULL
be	NULL
a	NULL
member	NULL
of	NULL
the	NULL
AP-1	NULL
family	NULL
of	NULL
transcriptional	NULL
factors	NULL
(	NULL
6	NULL
,	NULL
7	NULL
,	NULL
9	NULL
,	NULL
10	NULL
)	NULL
.	NULL

p21	NULL
``	NULL
is	NULL
well	NULL
established	NULL
as	NULL
an	NULL
in-ducer	NULL
and	NULL
regulator	NULL
of	NULL
AP-1	NULL
in	NULL
fibroblasts	NULL
(	NULL
38	NULL
)	NULL
.	NULL

The	NULL
present	NULL
data	NULL
confirm	NULL
that	NULL
p21	NULL
``	NULL
is	NULL
also	NULL
able	NULL
to	NULL
induce	NULL
AP-1-medi-ated	NULL
transcription	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
whereas	NULL
calcineurin	NULL
has	NULL
no	NULL
apparent	NULL
regulatory	NULL
effect	NULL
.	NULL

It	NULL
is	NULL
most	NULL
probable	NULL
,	NULL
therefore	NULL
,	NULL
that	NULL
in	NULL
the	NULL
cooperation	NULL
between	NULL
p21	NULL
``	NULL
*	NULL
and	NULL
calcineurin	NULL
,	NULL
Ras	NULL
would	NULL
contribute	NULL
to	NULL
NFAT	NULL
induction	NULL
via	NULL
control	NULL
of	NULL
AP-1	NULL
proteins	NULL
,	NULL
while	NULL
calcineurin	NULL
would	NULL
regulate	NULL
NFAT	NULL
by	NULL
control	NULL
of	NULL
the	NULL
subcellular	NULL
localization	NULL
of	NULL
the	NULL
calcium-responsive	NULL
NFAT	NULL
subunit	NULL
.	NULL

This	NULL
model	NULL
for	NULL
the	NULL
cooperative	NULL
interaction	NULL
between	NULL
calcineurin	NULL
and	NULL
Ras	NULL
in	NULL
NFAT	NULL
induction	NULL
warrants	NULL
further	NULL
ex-ploration	NULL
.	NULL

One	NULL
complication	NULL
lies	NULL
in	NULL
the	NULL
fact	NULL
that	NULL
the	NULL
AP-1	NULL
proteins	NULL
are	NULL
a	NULL
large	NULL
heterogeneous	NULL
family	NULL
of	NULL
transcriptional	NULL
factors	NULL
,	NULL
which	NULL
come	NULL
together	NULL
in	NULL
various	NULL
combinations	NULL
of	NULL
Fos	NULL
and	NULL
Jun	NULL
homo-	NULL
and	NULL
heterodimers	NULL
to	NULL
form	NULL
functional	NULL
complexes	NULL
(	NULL
39	NULL
)	NULL
.	NULL

When	NULL
T	NULL
cells	NULL
are	NULL
activated	NULL
,	NULL
they	NULL
express	NULL
multiple	NULL
Fos	NULL
and	NULL
Jun	NULL
proteins	NULL
(	NULL
40	NULL
)	NULL
,	NULL
and	NULL
the	NULL
identity	NULL
of	NULL
the	NULL
particular	NULL
partners	NULL
present	NULL
in	NULL
the	NULL
AP-1	NULL
complex	NULL
that	NULL
contribute	NULL
to	NULL
NFAT	NULL
induction	NULL
is	NULL
not	NULL
yet	NULL
clear	NULL
(	NULL
7	NULL
,	NULL
9	NULL
,	NULL
10	NULL
)	NULL
.	NULL

The	NULL
downstream	NULL
effectors	NULL
of	NULL
both	NULL
p21	NULL
``	NULL
and	NULL
calcineurin	NULL
are	NULL
not	NULL
known	NULL
.	NULL

One	NULL
potential	NULL
Ras	NULL
regulated	NULL
pathway	NULL
that	NULL
could	NULL
contribute	NULL
to	NULL
NFAT	NULL
regulation	NULL
is	NULL
the	NULL
MAP	NULL
kinase	NULL
signaling	NULL
cascade	NULL
(	NULL
41	NULL
)	NULL
.	NULL

p21	NULL
``	NULL
can	NULL
regulate	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
MAP	NULL
kinase	NULL
Erk2	NULL
in	NULL
Jurkat	NULL
cells	NULL
(	NULL
42	NULL
)	NULL
.	NULL

Substrates	NULL
for	NULL
Erk2	NULL
include	NULL
transcriptional	NULL
factors	NULL
such	NULL
as	NULL
the	NULL
AP1	NULL
member	NULL
c-jun	NULL
,	NULL
and	NULL
Elk-1	NULL
,	NULL
protein	NULL
that	NULL
complexes	NULL
with	NULL
serum	NULL
response	NULL
factor	NULL
to	NULL
transactivate	NULL
the	NULL
c-fos	NULL
promoter	NULL
,	NULL
whose	NULL
function	NULL
is	NULL
controlled	NULL
by	NULL
phosphorylation	NULL
at	NULL
target	NULL
sites	NULL
for	NULL
the	NULL
MAP	NULL
kinase	NULL
family	NULL
(	NULL
43-45	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
MAP	NULL
kinases	NULL
could	NULL
be	NULL
integral	NULL
to	NULL
the	NULL
signaling	NULL
pathways	NULL
that	NULL
couple	NULL
the	NULL
TCR	NULL
and	NULL
p21	NULL
``	NULL
to	NULL
the	NULL
cell	NULL
nucleus	NULL
.	NULL

The	NULL
potential	NULL
for	NULL
cooperation	NULL
between	NULL
p21	NULL
``	NULL
and	NULL
cal	NULL
cineurin	NULL
has	NULL
not	NULL
been	NULL
observed	NULL
in	NULL
previous	NULL
studies	NULL
of	NULL
Ras	NULL
function	NULL
in	NULL
other	NULL
cell	NULL
types	NULL
.	NULL

However	NULL
,	NULL
the	NULL
idea	NULL
that	NULL
Ras	NULL
controlled	NULL
signaling	NULL
pathways	NULL
are	NULL
not	NULL
alone	NULL
sufficient	NULL
for	NULL
cell	NULL
activation	NULL
is	NULL
not	NULL
novel	NULL
.	NULL

For	NULL
example	NULL
,	NULL
oncogenic	NULL
transformation	NULL
in	NULL
fibroblasts	NULL
requires	NULL
a	NULL
cooperative	NULL
interaction	NULL
between	NULL
Ras	NULL
and	NULL
other	NULL
oncogenes	NULL
(	NULL
46	NULL
)	NULL
.	NULL

The	NULL
demonstration	NULL
herein	NULL
that	NULL
Ras	NULL
and	NULL
calcineurin	NULL
can	NULL
cooperate	NULL
to	NULL
activate	NULL
T	NULL
cells	NULL
raises	NULL
the	NULL
possibility	NULL
that	NULL
calcineurin	NULL
could	NULL
be	NULL
a	NULL
protooncogene	NULL
.	NULL

Thus	NULL
,	NULL
mutations	NULL
in	NULL
calcineurin	NULL
or	NULL
mutations	NULL
that	NULL
perturbed	NULL
the	NULL
regulation	NULL
of	NULL
calcineurin	NULL
could	NULL
be	NULL
oncogenic	NULL
if	NULL
they	NULL
occurred	NULL
in	NULL
cells	NULL
expressing	NULL
oncogenic	NULL
Ras	NULL
.	NULL

Defects	NULL
in	NULL
NFAT	NULL
regulation	NULL
have	NULL
profound	NULL
functional	NULL
consequences	NULL
for	NULL
T	NULL
cells	NULL
,	NULL
as	NULL
judged	NULL
by	NULL
the	NULL
immunosuppressive	NULL
effects	NULL
of	NULL
the	NULL
drugs	NULL
cyclosporin	NULL
A	NULL
and	NULL
FK506	NULL
that	NULL
inhibit	NULL
the	NULL
action	NULL
of	NULL
calcineurin	NULL
on	NULL
NFAT	NULL
induction	NULL
(	NULL
33	NULL
)	NULL
.	NULL

The	NULL
realization	NULL
that	NULL
p21	NULL
``	NULL
is	NULL
an	NULL
important	NULL
partner	NULL
with	NULL
calcineurin	NULL
in	NULL
NFAT	NULL
regulation	NULL
suggests	NULL
that	NULL
Ras	NULL
could	NULL
also	NULL
be	NULL
an	NULL
important	NULL
target	NULL
for	NULL
immunosuppression	NULL
.	NULL

Alternatively	NULL
,	NULL
any	NULL
defects	NULL
in	NULL
Ras	NULL
regulation	NULL
would	NULL
have	NULL
severe	NULL
immune	NULL
conse-quences	NULL
.	NULL

This	NULL
is	NULL
supported	NULL
by	NULL
a	NULL
recent	NULL
study	NULL
in	NULL
nonobese	NULL
diabetic	NULL
fice	NULL
,	NULL
in	NULL
which	NULL
mature	NULL
(	NULL
CD4	NULL
CD4~8+*	NULL
)	NULL
T	NULL
cells	NULL
were	NULL
not	NULL
only	NULL
unable	NULL
to	NULL
proliferate	NULL
in	NULL
response	NULL
to	NULL
TCR	NULL
cross-linking	NULL
,	NULL
but	NULL
could	NULL
not	NULL
demonstrate	NULL
activation	NULL
of	NULL
p21	NULL
``	NULL
or	NULL
p42	NULL
``	NULL
**	NULL
after	NULL
ligation	NULL
of	NULL
the	NULL
TCR	NULL
(	NULL
47	NULL
)	NULL
.	NULL

Direct	NULL
stimulation	NULL
of	NULL
PKC	NULL
was	NULL
able	NULL
to	NULL
activate	NULL
p21	NULL
``	NULL
,	NULL
and	NULL
also	NULL
to	NULL
restore	NULL
the	NULL
cells	NULL
'	NULL
ability	NULL
to	NULL
grow	NULL
in	NULL
response	NULL
to	NULL
TCR	NULL
signaling	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
a	NULL
defect	NULL
must	NULL
exist	NULL
between	NULL
the	NULL
TCR	NULL
and	NULL
the	NULL
proteins	NULL
in	NULL
these	NULL
anergic	NULL
cells	NULL
,	NULL
supporting	NULL
the	NULL
hypothesis	NULL
that	NULL
p21	NULL
``	NULL
may	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
generation	NULL
of	NULL
an	NULL
immune	NULL
response	NULL
.	NULL

However	NULL
,	NULL
it	NULL
remains	NULL
to	NULL
be	NULL
seen	NULL
if	NULL
Ras	NULL
defects	NULL
exist	NULL
in	NULL
other	NULL
anergic	NULL
T	NULL
cell	NULL
models	NULL
or	NULL
autoimmune	NULL
diseases	NULL
.	NULL

The	NULL
authors	NULL
would	NULL
like	NULL
to	NULL
thank	NULL
P.	NULL
Parker	NULL
,	NULL
E.	NULL
Rozengurt	NULL
,	NULL
S.	NULL
Rayter	NULL
,	NULL
and	NULL
G.	NULL
Crabtree	NULL
for	NULL
helpful	NULL
comments	NULL
on	NULL
the	NULL
manuscript	NULL
.	NULL

Address	NULL
correspondence	NULL
to	NULL
Dr.	NULL
Melissa	NULL
A.	NULL
Woodrow	NULL
,	NULL
Lymphocyte	NULL
Activation	NULL
Laboratory	NULL
,	NULL
Imperial	NULL
Cancer	NULL
Research	NULL
Fund	NULL
,	NULL
Room	NULL
613	NULL
,	NULL
Lincoln	NULL
's	NULL
Inn	NULL
Fields	NULL
,	NULL
London	NULL
,	NULL
WCZA	NULL
3PX	NULL
,	NULL
UK	NULL
.	NULL

Received	NULL
for	NULL
publication	NULL
24	NULL
May	NULL
1993	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
2	NULL
August	NULL
1993	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Smith	NULL
,	NULL
K.A	NULL
.	NULL

1988	NULL
.	NULL

Interleukin-2	NULL
:	NULL
inception	NULL
,	NULL
impact	NULL
and	NULL
im-plications	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

240:1169	NULL
.	NULL

2	NULL
.	NULL

Crabtree	NULL
,	NULL
G.R	NULL
.	NULL

1989	NULL
.	NULL

Contingent	NULL
genetic	NULL
regulatory	NULL
events	NULL
in	NULL
T	NULL
lymphocyte	NULL
activation	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

243:355	NULL
.	NULL

3	NULL
.	NULL

Durand	NULL
,	NULL
D.B	NULL
.	NULL

,	NULL
M.R	NULL
.	NULL

Bush	NULL
,	NULL
J.G	NULL
.	NULL

Morgan	NULL
,	NULL
A.	NULL
Weiss	NULL
,	NULL
and	NULL
G.R	NULL
.	NULL

Crabtree	NULL
.	NULL

1987	NULL
.	NULL

A	NULL
275	NULL
basepair	NULL
fragment	NULL
at	NULL
the	NULL
5	NULL
end	NULL
of	NULL
the	NULL
interleukin	NULL
2	NULL
gene	NULL
enhances	NULL
expression	NULL
from	NULL
a	NULL
heterologous	NULL
promoter	NULL
in	NULL
response	NULL
to	NULL
signals	NULL
from	NULL
the	NULL
T	NULL
cell	NULL
antigen	NULL
receptor	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

165:395	NULL
.	NULL

4	NULL
.	NULL

Emmel	NULL
,	NULL
EA	NULL
.	NULL

,	NULL
C.L	NULL
.	NULL

Verweij	NULL
,	NULL
D.B	NULL
.	NULL

Durand	NULL
,	NULL
K.M	NULL
.	NULL

Higgins	NULL
,	NULL
E.	NULL
Lacy	NULL
,	NULL
and	NULL
G.R	NULL
.	NULL

Crabtree	NULL
.	NULL

1989	NULL
.	NULL

Cyclosporin	NULL
A	NULL
specifically	NULL
inhibits	NULL
function	NULL
of	NULL
nuclear	NULL
proteins	NULL
involved	NULL
in	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

246:1617	NULL
.	NULL

5	NULL
.	NULL

Verweij	NULL
,	NULL
CL	NULL
.	NULL

,	NULL
C.	NULL
Guidos	NULL
,	NULL
and	NULL
G.R	NULL
.	NULL

Crabtree	NULL
.	NULL

1990	NULL
.	NULL

Cell	NULL
type	NULL
1521	NULL
Woodrow	NULL
et	NULL
al	NULL
.	NULL

specificity	NULL
and	NULL
activation	NULL
requirements	NULL
for	NULL
NFAT-1	NULL
(	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T-cells	NULL
)	NULL
transcriptional	NULL
activity	NULL
determined	NULL
by	NULL
a	NULL
new	NULL
method	NULL
using	NULL
transgenic	NULL
mice	NULL
to	NULL
assay	NULL
transcriptional	NULL
activity	NULL
of	NULL
an	NULL
activated	NULL
nuclear	NULL
factor	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

265:15788	NULL
.	NULL

6	NULL
.	NULL

Flanagan	NULL
,	NULL
W.M	NULL
.	NULL

,	NULL
B.	NULL
CorthÃ©sy	NULL
,	NULL
R.J.	NULL
Bram	NULL
,	NULL
and	NULL
G.R	NULL
.	NULL

Crabtree	NULL
.	NULL

1991	NULL
.	NULL

Nuclear	NULL
association	NULL
of	NULL
a	NULL
T-cell	NULL
transcription	NULL
factor	NULL
blocked	NULL
by	NULL
FK-506	NULL
and	NULL
cyclosporin	NULL
A	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

352:803	NULL
.	NULL

7	NULL
.	NULL

Jain	NULL
,	NULL
J.	NULL
,	NULL
PG	NULL
.	NULL

McCaffrey	NULL
,	NULL
V.E	NULL
.	NULL

Valge-Archer	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1992	NULL
.	NULL

Nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
contains	NULL
Fos	NULL
and	NULL
Jun	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

356:801	NULL
.	NULL

8	NULL
.	NULL

McCaffrey	NULL
,	NULL
PG	NULL
.	NULL

,	NULL
B.A	NULL
.	NULL

Perrino	NULL
,	NULL
TR	NULL
.	NULL

Soderling	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1993	NULL
.	NULL

NF-ATp	NULL
,	NULL
a	NULL
T	NULL
lymphocyte	NULL
DNA-binding	NULL
protein	NULL
that	NULL
is	NULL
a	NULL
target	NULL
for	NULL
calcineurin	NULL
and	NULL
immunosuppressive	NULL
drugs	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268:3747	NULL
.	NULL

10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27.	NULL
.	NULL

Northrop	NULL
,	NULL
J.P.	NULL
,	NULL
K.S	NULL
.	NULL

Ullman	NULL
,	NULL
and	NULL
G.R	NULL
.	NULL

Crabtree	NULL
.	NULL

1993	NULL
.	NULL

Char	NULL
acterization	NULL
of	NULL
the	NULL
nuclear	NULL
and	NULL
cytoplasmic	NULL
components	NULL
of	NULL
the	NULL
lymphoid	NULL
specific	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
NF-AT	NULL
)	NULL
complex	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268:2917	NULL
.	NULL

Boise	NULL
,	NULL
L.H	NULL
.	NULL

,	NULL
B.	NULL
Petryniak	NULL
,	NULL
X.	NULL
Mao	NULL
,	NULL
C.H	NULL
.	NULL

June	NULL
,	NULL
C.-Y	NULL
.	NULL

Wang	NULL
,	NULL
T.	NULL
Lindsten	NULL
,	NULL
R.	NULL
Bravo	NULL
,	NULL
K.	NULL
Kovary	NULL
,	NULL
J.M	NULL
.	NULL

Leiden	NULL
,	NULL
and	NULL
C.B	NULL
.	NULL

Thompson	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
NFAT-1	NULL
DNA	NULL
binding	NULL
complex	NULL
in	NULL
activated	NULL
T	NULL
cells	NULL
contains	NULL
Fra-1	NULL
and	NULL
JunB	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:1911	NULL
.	NULL

Durand	NULL
,	NULL
D.B	NULL
.	NULL

,	NULL
J.-P.	NULL
Shaw	NULL
,	NULL
M.R	NULL
.	NULL

Bush	NULL
,	NULL
RE	NULL
.	NULL

Replogle	NULL
,	NULL
R.	NULL
Be-lagaje	NULL
,	NULL
and	NULL
G.R	NULL
.	NULL

Crabtree	NULL
.	NULL

1988	NULL
.	NULL

Characterization	NULL
of	NULL
antigen	NULL
receptor	NULL
response	NULL
elements	NULL
within	NULL
the	NULL
interleukin-2	NULL
enhancer	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

8:1715	NULL
.	NULL

Weiss	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
J.B.	NULL
Imboden	NULL
.	NULL

1987	NULL
.	NULL

Cell	NULL
surface	NULL
molecules	NULL
and	NULL
early	NULL
events	NULL
involved	NULL
in	NULL
human	NULL
T	NULL
lymphocyte	NULL
activation	NULL
.	NULL

Adv	NULL
.	NULL

Immunol	NULL
.	NULL

41:1	NULL
.	NULL

Hivroz-Burgaud	NULL
,	NULL
C.	NULL
,	NULL
N.	NULL
Clipstone	NULL
,	NULL
and	NULL
D.	NULL
Cantrell	NULL
.	NULL

1991	NULL
.	NULL

Signaling	NULL
requirements	NULL
for	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
transactivation	NULL
factor	NULL
NF-AT	NULL
in	NULL
human	NULL
T	NULL
lymphocytes	NULL
.	NULL

Eur	NULL
J.	NULL
Immunol	NULL
.	NULL

21:2811	NULL
.	NULL

Matilla	NULL
,	NULL
PS	NULL
.	NULL

,	NULL
K.S	NULL
.	NULL

Ullman	NULL
,	NULL
S.	NULL
Fiering	NULL
,	NULL
EA	NULL
.	NULL

Emmel	NULL
,	NULL
M.	NULL
McCutcheon	NULL
,	NULL
G.R	NULL
.	NULL

Crabtree	NULL
,	NULL
and	NULL
L.A.	NULL
Herzenberg	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
actions	NULL
of	NULL
cyclosporin	NULL
A	NULL
and	NULL
FK506	NULL
suggest	NULL
a	NULL
novel	NULL
step	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
T	NULL
lymphocytes	NULL
.	NULL

EMBO	NULL
(	NULL
Eur	NULL
.	NULL

Mol	NULL
.	NULL

Biol	NULL
.	NULL

Organ	NULL
.	NULL
)	NULL

J	NULL
.	NULL

94425	NULL
.	NULL

Downward	NULL
,	NULL
J.	NULL
,	NULL
J.D	NULL
.	NULL

Graves	NULL
,	NULL
P.H	NULL
.	NULL

Warne	NULL
,	NULL
S.	NULL
Rayter	NULL
,	NULL
and	NULL
D.A	NULL
.	NULL

Cantrell	NULL
.	NULL

1990	NULL
.	NULL

Stimulation	NULL
of	NULL
p21	NULL
``	NULL
upon	NULL
T-cell	NULL
activation	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

346:719	NULL
.	NULL

Downward	NULL
,	NULL
J.	NULL
,	NULL
J.D	NULL
.	NULL

Graves	NULL
,	NULL
and	NULL
D.	NULL
A.	NULL
Cantrell	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
regulation	NULL
and	NULL
function	NULL
of	NULL
p21	NULL
``	NULL
in	NULL
T	NULL
lymphocytes	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
.	NULL

13:89	NULL
.	NULL

Downward	NULL
,	NULL
J	NULL
.	NULL

1992	NULL
.	NULL

Regulation	NULL
of	NULL
p21	NULL
``	NULL
``	NULL
by	NULL
GAPs	NULL
and	NULL
guanine	NULL
nucleotide	NULL
exchange	NULL
proteins	NULL
in	NULL
normal	NULL
and	NULL
oncogenic	NULL
cells	NULL
.	NULL

Curr	NULL
Opin	NULL
.	NULL

Dev	NULL
.	NULL

Genet	NULL
.	NULL

2:13	NULL
.	NULL

Graves	NULL
,	NULL
J.D	NULL
.	NULL

,	NULL
J	NULL
.	NULL

Downward	NULL
,	NULL
S.	NULL
Rayter	NULL
,	NULL
P.	NULL
Warne	NULL
,	NULL
A.L	NULL
.	NULL

Tutt	NULL
,	NULL
M.	NULL
Glennie	NULL
,	NULL
and	NULL
D.A	NULL
.	NULL

Cantrell	NULL
.	NULL

1991	NULL
.	NULL

CD2	NULL
antigen	NULL
mediated	NULL
activation	NULL
of	NULL
the	NULL
guanine	NULL
nucleotide	NULL
binding	NULL
proteins	NULL
p21	NULL
``	NULL
in	NULL
human	NULL
T	NULL
lymphocytes	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

146:3709	NULL
.	NULL

Izquierdo	NULL
,	NULL
M.	NULL
,	NULL
J	NULL
.	NULL

Downward	NULL
,	NULL
J.D	NULL
.	NULL

Graves	NULL
,	NULL
and	NULL
D.	NULL
A.	NULL
Cantrell	NULL
.	NULL

1992	NULL
.	NULL

Role	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
in	NULL
T-cell	NULL
antigen	NULL
receptor	NULL
regulation	NULL
of	NULL
p21	NULL
``	NULL
:	NULL
evidence	NULL
that	NULL
two	NULL
p21	NULL
``	NULL
regulatory	NULL
pathways	NULL
coexist	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:3305	NULL
.	NULL

Rayter	NULL
,	NULL
S.	NULL
,	NULL
M.	NULL
Woodrow	NULL
,	NULL
D.	NULL
Cantrell	NULL
,	NULL
and	NULL
J	NULL
.	NULL

Downward	NULL
.	NULL

1992.	NULL
p21	NULL
``	NULL
mediates	NULL
control	NULL
of	NULL
IL2	NULL
gene	NULL
promoter	NULL
function	NULL
in	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

EMBO	NULL
(	NULL
Eur	NULL
.	NULL

Mol	NULL
.	NULL

Biol	NULL
.	NULL

Organ	NULL
.	NULL
)	NULL

J	NULL
.	NULL

11:4549	NULL
.	NULL

Woodrow	NULL
,	NULL
M.A	NULL
.	NULL

,	NULL
S.	NULL
Rayter	NULL
,	NULL
J	NULL
.	NULL

Downward	NULL
,	NULL
and	NULL
D.A	NULL
.	NULL

Cantrell	NULL
.	NULL

1993.	NULL
p21	NULL
``	NULL
function	NULL
is	NULL
important	NULL
for	NULL
T	NULL
cell	NULL
antigen	NULL
receptor	NULL
and	NULL
protein	NULL
kinase	NULL
C	NULL
regulation	NULL
of	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

150:1	NULL
.	NULL

O'Keefe	NULL
,	NULL
S.J	NULL
.	NULL

,	NULL
J.	NULL
Tamura	NULL
,	NULL
RL	NULL
.	NULL

Kincaid	NULL
,	NULL
M.J.	NULL
Tocci	NULL
,	NULL
and	NULL
E.A	NULL
.	NULL

O'Neill	NULL
.	NULL

1992	NULL
.	NULL

FK-506	NULL
and	NULL
Cs-A-sensitive	NULL
activation	NULL
of	NULL
the	NULL
interleukin-2	NULL
promoter	NULL
by	NULL
calcineurin	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

357:692	NULL
.	NULL

Clipstone	NULL
,	NULL
N.A	NULL
.	NULL

,	NULL
and	NULL
G.R	NULL
.	NULL

Crabtree	NULL
.	NULL

1992	NULL
.	NULL

Identification	NULL
of	NULL
calcineurin	NULL
as	NULL
a	NULL
key	NULL
signalling	NULL
enzyme	NULL
in	NULL
T-lymphocyte	NULL
activation	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

357:695	NULL
.	NULL

McKeon	NULL
,	NULL
F.	NULL
1991	NULL
.	NULL

When	NULL
worlds	NULL
collide	NULL
:	NULL
immunosuppressants	NULL
meet	NULL
protein	NULL
phosphatases	NULL
.	NULL

Cell	NULL
.	NULL

66:823	NULL
.	NULL

Schreiber	NULL
,	NULL
S.L	NULL
.	NULL

1992	NULL
.	NULL

Immunophilin-sensitive	NULL
protein	NULL
phosphatase	NULL
action	NULL
in	NULL
cell	NULL
signalling	NULL
pathways	NULL
.	NULL

Cell	NULL
.	NULL

70:365	NULL
.	NULL

Fruman	NULL
,	NULL
D.A	NULL
.	NULL

,	NULL
C.B	NULL
.	NULL

Klee	NULL
,	NULL
B.E	NULL
.	NULL

Bierer	NULL
,	NULL
and	NULL
S.J	NULL
.	NULL

Burakoff	NULL
.	NULL

1992	NULL
.	NULL

Phosphatase	NULL
activity	NULL
in	NULL
T	NULL
lymphocytes	NULL
is	NULL
inhibited	NULL
by	NULL
FK-506	NULL
and	NULL
cyclosporin	NULL
A.	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

89:3686	NULL
.	NULL

Beverley	NULL
,	NULL
PC.L	NULL
.	NULL

,	NULL
and	NULL
R.E	NULL
.	NULL

Callard	NULL
.	NULL

1981	NULL
.	NULL

Distinctive	NULL
functional	NULL
characteristics	NULL
of	NULL
human	NULL
T	NULL
lymphocytes	NULL
defined	NULL
by	NULL
E	NULL
roset-	NULL
1522	NULL
28	NULL
.	NULL

29	NULL
,	NULL
30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47.	NULL
ting	NULL
or	NULL
monoclonal	NULL
anti-T	NULL
cell	NULL
antibody	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

11:329	NULL
.	NULL

Mizushima	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
S.	NULL
Nagata	NULL
.	NULL

1990.	NULL
pEF-BOS	NULL
,	NULL
a	NULL
powerful	NULL
mammalian	NULL
expression	NULL
vector	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

18:5322	NULL
.	NULL

Clipstone	NULL
,	NULL
N.A	NULL
.	NULL

,	NULL
and	NULL
G.R	NULL
.	NULL

Crabtree	NULL
.	NULL

1993	NULL
.	NULL

Calcineurin	NULL
is	NULL
a	NULL
key	NULL
signalling	NULL
enzyme	NULL
in	NULL
T	NULL
lymphocyte	NULL
activation	NULL
and	NULL
the	NULL
target	NULL
of	NULL
the	NULL
immunosuppressive	NULL
drugs	NULL
CsA	NULL
and	NULL
FK506	NULL
.	NULL

Ann	NULL
.	NULL

N.	NULL
Y.	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

In	NULL
press	NULL
.	NULL

Sleigh	NULL
,	NULL
M.J.	NULL
1986	NULL
.	NULL

A	NULL
nonchromatographic	NULL
assay	NULL
for	NULL
expression	NULL
of	NULL
the	NULL
chloramphenicol	NULL
acetyltransferase	NULL
gene	NULL
in	NULL
eucaryotic	NULL
cells	NULL
.	NULL

Anal	NULL
.	NULL

Biochem	NULL
.	NULL

156:251	NULL
.	NULL

Capon	NULL
,	NULL
E.	NULL
,	NULL
E.	NULL
Chen	NULL
,	NULL
A.	NULL
Levinson	NULL
,	NULL
P.	NULL
Seeburg	NULL
,	NULL
and	NULL
D.	NULL
Goeddel	NULL
.	NULL

1983	NULL
.	NULL

Complete	NULL
nucleotide	NULL
sequence	NULL
of	NULL
the	NULL
T24	NULL
human	NULL
bladder	NULL
carcinoma	NULL
oncogene	NULL
and	NULL
its	NULL
normal	NULL
homologue	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

302:33	NULL
.	NULL

McCormick	NULL
,	NULL
F.	NULL
1989.	NULL
ras	NULL
GTPase	NULL
activating	NULL
protein	NULL
:	NULL
signal	NULL
transmitter	NULL
and	NULL
signal	NULL
terminator	NULL
.	NULL

Cell	NULL
.	NULL

56:5	NULL
.	NULL

Schreiber	NULL
,	NULL
S.L	NULL
.	NULL

,	NULL
and	NULL
G.R	NULL
.	NULL

Crabtree	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
mechanism	NULL
of	NULL
action	NULL
of	NULL
cyclosporin	NULL
A	NULL
and	NULL
FK506	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
.	NULL

13:136	NULL
.	NULL

Baldari	NULL
,	NULL
CT.	NULL
,	NULL
A.	NULL
Heguy	NULL
,	NULL
and	NULL
J.L	NULL
.	NULL

Telford	NULL
.	NULL

1993.	NULL
ras	NULL
protein	NULL
activity	NULL
is	NULL
essential	NULL
for	NULL
T-cell	NULL
antigen	NULL
receptor	NULL
signal	NULL
transduc-tion	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268:2693	NULL
.	NULL

Baldari	NULL
,	NULL
CT.	NULL
,	NULL
A.	NULL
Heguy	NULL
,	NULL
and	NULL
J.L	NULL
.	NULL

Telford	NULL
.	NULL

1993	NULL
.	NULL

Calcium-dependent	NULL
cyclosporin	NULL
A-sensitive	NULL
activation	NULL
of	NULL
the	NULL
interleukin-2	NULL
promoter	NULL
by	NULL
p59	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268:8406	NULL
.	NULL

Baldari	NULL
,	NULL
CT.	NULL
,	NULL
A.	NULL
Heguy	NULL
,	NULL
and	NULL
J.L	NULL
.	NULL

Telford	NULL
.	NULL

1993	NULL
.	NULL

Calcium	NULL
dependent	NULL
activation	NULL
of	NULL
the	NULL
NF-AT	NULL
transcription	NULL
factor	NULL
by	NULL
p5659	NULL
``	NULL
.	NULL

FEBS	NULL
(	NULL
Fed	NULL
.	NULL

Eur	NULL
.	NULL

Biochem	NULL
.	NULL

Soc	NULL
.	NULL
)	NULL

Lett	NULL
.	NULL

323:233	NULL
.	NULL

Liu	NULL
,	NULL
J.	NULL
,	NULL
J.D	NULL
.	NULL

Farmer	NULL
,	NULL
W.S	NULL
.	NULL

Lane	NULL
,	NULL
J.	NULL
Friedman	NULL
,	NULL
I.	NULL
Weissman	NULL
,	NULL
and	NULL
S.L	NULL
.	NULL

Schreiber	NULL
.	NULL

1991	NULL
.	NULL

Calcineurin	NULL
is	NULL
a	NULL
common	NULL
target	NULL
of	NULL
cyclophilin	NULL
,	NULL
cyclosporin	NULL
A	NULL
,	NULL
and	NULL
FKBP-FK506	NULL
complexes	NULL
.	NULL

Cell	NULL
.	NULL

66:807	NULL
.	NULL

Smeal	NULL
,	NULL
T.	NULL
,	NULL
B.	NULL
Binetruy	NULL
,	NULL
D.A	NULL
.	NULL

Mercola	NULL
,	NULL
M.	NULL
Birrer	NULL
,	NULL
and	NULL
M.	NULL
Karin	NULL
.	NULL

1991	NULL
.	NULL

Oncogenic	NULL
and	NULL
transcriptional	NULL
cooperation	NULL
with	NULL
Ha-Ras	NULL
requires	NULL
phosphorylation	NULL
of	NULL
c-Jun	NULL
on	NULL
serines	NULL
63	NULL
and	NULL
73	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

354:494	NULL
.	NULL

Angel	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
M.	NULL
Karin	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
role	NULL
of	NULL
Jun	NULL
,	NULL
Fos	NULL
,	NULL
and	NULL
the	NULL
AP-1	NULL
complex	NULL
in	NULL
cell-proliferation	NULL
and	NULL
transformation	NULL
.	NULL

Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
.	NULL

1072:129	NULL
.	NULL

Shibuya	NULL
,	NULL
H.	NULL
,	NULL
M.	NULL
Yoneyama	NULL
,	NULL
J.	NULL
Ninomiya	NULL
Tsuji	NULL
,	NULL
K.	NULL
Matsumoto	NULL
,	NULL
and	NULL
T.	NULL
Taniguchi	NULL
.	NULL

1992	NULL
.	NULL

IL-2	NULL
and	NULL
EGF	NULL
receptors	NULL
stimulate	NULL
the	NULL
hemopoietic	NULL
cell	NULL
cycle	NULL
via	NULL
different	NULL
signalling	NULL
pathways	NULL
:	NULL
demonstration	NULL
of	NULL
a	NULL
novel	NULL
role	NULL
for	NULL
c-myc	NULL
.	NULL

Cell	NULL
.	NULL

70:57	NULL
.	NULL

Ahn	NULL
,	NULL
N.G	NULL
.	NULL

,	NULL
R.	NULL
Seger	NULL
,	NULL
and	NULL
EG	NULL
.	NULL

Krebs	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
activator	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

4:992	NULL
.	NULL

Izquierdo	NULL
,	NULL
M.	NULL
,	NULL
S.J	NULL
.	NULL

Leevers	NULL
,	NULL
C.J	NULL
.	NULL

Marshall	NULL
,	NULL
and	NULL
D.	NULL
Cantrell	NULL
.	NULL

1993.	NULL
p21	NULL
``	NULL
couples	NULL
the	NULL
T	NULL
cell	NULL
antigen	NULL
receptor	NULL
to	NULL
extracel-lular	NULL
signal-regulated	NULL
kinase	NULL
2	NULL
in	NULL
T	NULL
lymphocytes	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

178:1199	NULL
.	NULL

Pulverer	NULL
,	NULL
BJ	NULL
.	NULL

,	NULL
J.M	NULL
.	NULL

Kyriakis	NULL
,	NULL
J.	NULL
Avruch	NULL
,	NULL
E.	NULL
Nikolakaki	NULL
,	NULL
and	NULL
J.R.	NULL
Woodgett	NULL
.	NULL

1991	NULL
.	NULL

Phosphorylation	NULL
of	NULL
c-jun	NULL
mediated	NULL
by	NULL
MAP	NULL
kinases	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

353:670	NULL
.	NULL

Hill	NULL
,	NULL
C.S	NULL
.	NULL

,	NULL
R.	NULL
Marais	NULL
,	NULL
S.	NULL
John	NULL
,	NULL
J.	NULL
Wynne	NULL
,	NULL
S.	NULL
Dalton	NULL
,	NULL
and	NULL
R.	NULL
Treisman	NULL
.	NULL

1993	NULL
.	NULL

Functional	NULL
analysis	NULL
of	NULL
a	NULL
growth	NULL
factor	NULL
responsive	NULL
transcription	NULL
factor	NULL
complex	NULL
.	NULL

Cell	NULL
.	NULL

73:395	NULL
.	NULL

Marais	NULL
,	NULL
R.	NULL
,	NULL
J.	NULL
Wynne	NULL
,	NULL
and	NULL
R.	NULL
Treisman	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
SRF	NULL
accessory	NULL
protein	NULL
ELK-1	NULL
contains	NULL
a	NULL
growth	NULL
factor-regulated	NULL
transcriptional	NULL
activation	NULL
domain	NULL
.	NULL

Cell	NULL
.	NULL

73:381	NULL
.	NULL

Hunter	NULL
,	NULL
T.	NULL
1991	NULL
.	NULL

Cooperation	NULL
between	NULL
oncogenes	NULL
.	NULL

Cell	NULL
.	NULL

64:249	NULL
.	NULL

Rapoport	NULL
,	NULL
M.J.	NULL
,	NULL
A.H.	NULL
Lazarus	NULL
,	NULL
A.	NULL
Jaramillo	NULL
,	NULL
E.	NULL
Speck	NULL
,	NULL
and	NULL
T.L	NULL
.	NULL

Delovitch	NULL
.	NULL

1993	NULL
.	NULL

Thymic	NULL
T	NULL
cell	NULL
anergy	NULL
in	NULL
autoimmune	NULL
nonobese	NULL
diabetic	NULL
mice	NULL
is	NULL
mediated	NULL
by	NULL
deficient	NULL
T	NULL
cell	NULL
receptor	NULL
regulation	NULL
of	NULL
the	NULL
pathway	NULL
of	NULL
p21	NULL
``	NULL
activation	NULL
.	NULL

J.	NULL
Exp	NULL
Med	NULL
.	NULL

177:1221	NULL
.	NULL

Ras	NULL
and	NULL
Calcineurin	NULL
Regulate	NULL
NFAT	NULL

